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 1 
1 Introduction 
Fertility problems have been among the main reasons for the slaughter of dairy cows for 
many years. In Germany and Austria infertility is also an important reason for culling of high-
performance dairy cows. Current statistics estimate the percentage of female cattle 
slaughtered due to fertility problems or infertility between 22 and 25% (Arbeitsgemeinschaft 
Deutscher Rinderzüchter, 2006). Reduced fertility of a herd results in additional costs for 
artificial insemination and veterinary treatment. An elongated empty period leads to extended 
lactations, often with reduced milk yield. In addition there are problems due to the lack of 
replacement heifers. Since these problems result in financial losses for the farmer and retard 
genetic progress, genetic improvement of fertility would be of great benefit (Gredler 2006). 
However, improvement of fertility via genetic selection is hampered by the low heritability 
(between 0.01 and 0.05) of currently recorded fertility traits, e.g. the non-return rate 90 days 
after artificial insemination. Besides the non-return rate a series of physiological supporting 
markers, which were partly shown to be marginally related with fertility, are discussed for the 
selection of fertile cows. These surrogate markers include the progesterone levels in the 
milk, the locomotor activity and the body temperature, which could enhance the efficiency of 
the recognition of standing heat. Also measurement of diverse components of the milk as 
well as a body condition score, which have been recommended as additional markers for the 
evaluation of fertility breeding values. However, these parameters are only indirectly related 
to the physiology and pathology of reproduction. Thus the search for new markers, which are 
directly associated with bovine fertility, is necessary. One idea to find such markers is to 
identify gene expression patterns in the endometrium that correlate with maternal fertility 
(Wolf, Arnold et al. 2006).  
The aim of this work was to identify genes with significant changes of mRNA concentrations 
in the bovine endometrium during the oestrous cycle as an important basis for future studies 
of endometrial transcriptome changes in normal reproductive physiology vs. pathologic 
conditions.  
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2 Approaches for the analysis of mRNA expression levels 
Mammalian genomes contain approximately 23,000 protein-coding genes and almost every 
cell contains this all-embracing genomic information. But every single cell type and also 
different tissues or physiological stages show a typical pattern of active genes, which are 
transcribed. Thus, valuable information about the regulation and the nature of biological 
processes at the molecular level can be deduced from analyses of differences in expression 
levels of mRNAs between different physiological states, such as stages of the oestrous 
cycle. 
For the analysis of small sets of candidate genes techniques like quantitative RT-PCR, in situ 
hybridisation and Northern blotting are used. However, for holistic analyses highly parallel 
techniques are applied which are either hybridisation- or sequencing-based. The first high-
performance sequencing platform was Massive Parallel Signature Sequencing (MPSS) 
(Reinartz, Bruyns et al. 2002). A sensitivity of a few mRNA molecules per cell was achieved 
by counting the frequencies of millions of short mRNA-derived sequence tags. Most recently, 
important advances have been made in speeding up DNA sequencing with the development 
of the so-called “next generation” sequencing instruments (Roche/ 454: Genome Sequencer 
FLX (Margulies, Egholm et al. 2005); ABI: SOLiD system; Illumina: 1G Genome Analyzer) 
that are able to produce millions of sequence tags per run. A short survey of current 
developments of next generation sequencing systems is presented in (Shaffer 2007). Due to 
their high performance, these new technologies are particularly suited for the analysis of 
mammalian transcriptomes and will enable the detection of rare transcripts in complex 
tissues like the endometrium in the future.  
The currently most widespread method for the analysis of mRNA expression levels is the 
hybridisation of microarrays. The microarray technology is based on the specific hybridisation 
of two complementary DNA strands or of complementary DNA and RNA sequences. Nucleic 
acids specific for certain mRNA sequences are immobilised as probes on a solid support and 
hybridised with labelled nucleic acids derived from mRNA isolated from the cells or tissues of 
interest. The amount of bound label corresponds to the concentration of the corresponding 
transcripts in the biological sample. There are several commercial microarray platforms 
performing genome-wide analyses by measurement of the transcription levels of several ten 
thousands of genes in a single experiment.  
Despite the high performance of microarray-based approaches, the reliability of 
measurements was often challenged due to inconsistent results that have been reported with 
different microarray platforms. However, the MicroArray Quality Control (MAQC) project has 
recently investigated a variety of microarray platforms and alternative technology platforms 
(Shi, Reid et al. 2006). Reproducible measurement of gene expression at multiple test sites 
was achieved as well as a high concordance with different platforms. Detailed analyses were 
done to compare performance of one- and two-colour systems (Patterson, Lobenhofer et al. 
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2006). Furthermore, the performance of five commercial microarray platforms and the impact 
of different normalisation methods for expression data were examined (Shippy, Fulmer-
Smentek et al. 2006). In order to determine the reliability of the quantification of gene 
expression, DNA microarray results were evaluated with three different quantitative gene 
expression platforms (Canales, Luo et al. 2006). High correlation was observed between 
quantitative gene expression values and microarray platform results. The only shortcoming of 
the different microarray platforms was the limited and variable sensitivity for detection of rare 
transcripts, which interferes with reproducible measurement of differentially expressed 
genes. Nevertheless, optimisation and standardisation of methods have enhanced the 
reproducibility of the results across platforms.  
The Affymetrix GeneChip® system is a widely used commercial platform which provides a 
number of arrays for domestic animals, such as cattle, pig, dog and chicken. The design of 
the Bovine Genome Array was based on content from Bovine UniGene Build 57 (March 24, 
2004) and GenBank® mRNAs. The GeneChip® Bovine Genome Array was developed 
through the GeneChip® Consortia Program, and contains 24,027 probe sets. Based on the 
original annotation (March 2004) these probe sets represented over 23,000 bovine 
transcripts and included approximately 19,000 UniGene clusters. However, according to the 
current state of the bovine Genome annotation and the current content of GenBank® the 
Bovine Genome Array represents only approximately 15,000 bovine genes (personal 
communication – Volker Hintermair, Department of Practical Informatics and Bioinformatics, 
LMU Munich). Gene specific oligonucleotides (from the 3’ untranslated region of the mRNA) 
are synthesised directly on quartz wafers by a photolithographic process. Hybridisation of the 
arrays is carried out with biotinylated cRNA, which can be detected after hybridisation 
through fluorescently labelled streptavidin (www.affymetrix.com).  
Large microarrays such as the Affymetrix Bovine Genome Array are well suited for the 
screening for differentially expressed genes in a broad range of applications. For more 
specialised applications like the analysis of dynamic mRNA expression profiles in bovine 
endometrium during the oestrous cycle or early pregnancy smaller and more flexible arrays 
mainly containing probes for the genes of interest (i.e. the differentially expressed genes) 
would be beneficial. Furthermore, the application of a custom-made array based on spotted 
cDNAs or oligonucleotides for the analysis of gene expression of a limited number of genes 
would be less expensive and would simplify the interpretation of expression data. Based on a 
series of differential gene expression studies of bovine endometrium (different stages of the 
oestrous cycle, d 18 pregnant vs. nonpregnant) and oviduct epithelial cells (different stages 
of the oestrous cycle), a custom-made Bovine Oviduct and Endometrium (BOE) cDNA array 
was developed as a basis for the analysis of endometrial mRNA expression profiles 
corresponding to normal reproductive physiology and in pathological conditions (Publication 
1). 
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3 The bovine uterus 
The function of the bovine uterus is to supply the conceptus - via the contact with the fetal 
membranes - with oxygen and nutrients. At the end of the pregnancy the uterus has to drive 
out the calf during parturition. All these processes occur under complex hormonal regulation. 
Due to its morphology, the bovine uterus is referred to as uterus bicornis. It consists of two 
uterine horns (cornua uteri), the uterine body (corpus uteri), and the uterine neck (cervix 
uteri). These horns are two tubes with cranial decreasing diameter, which are lying in parallel 
in the first part next to the uterine body. Both horns are rolled-up like a snail. The uterine 
walls consist of the endometrium with the luminal epithelium (LE) in one or more layers and 
the propria with the uterine glands and connective tissue, beneath the endometrium the 
tunica muscularis or myometrium and the tunica serosa or perimetrium. The endometrium is 
subdivided in caruncular and intercaruncular parts. The main difference between these parts 
is the lack of uterine glands in the caruncles. After implantation of an embryo, the 75 to 120 
caruncles grow rapidly and form the placentomes, tight connections between the 
endometrium and the fetal parts of the placenta (cotyledons) facilitating the exchange of 
small molecules (Nickel, Schummer et al. 1999). 
Implantation in cattle is non-invasive (placenta epitheliochorialis) and follows an extended 
pre-implantation period where most embryo deaths occur (Burghardt, Johnson et al. 2002). 
Only a limited number of trophoblast cells show a fusion with luminal epithelial cells forming 
so-called trophoblast giant cells. There are dramatic differences compared to the early and 
invasive implantation in rodents and humans. During the oestrous cycle there is also no 
decidualisation, which is present in primates. Due to the extended pre-implantation period 
the endometrium secretes histotroph, an uterine secretion product containing e.g. uteroferrin 
and protease inhibitors to nourish the conceptus for proper development (Roberts and Bazer 
1988). During the pre-attachment period in ruminant species the hatched blastocyst 
elongates rapidly to form a filamentous conceptus that signals for maternal recognition of 
pregnancy (Ruesse and Sinowatz 1998). The biochemical events of the pre-implantation 
period provide a unique time span, absolutely critical for embryonic survival, to study the 
adhesion and signal transduction events associated with apposition and attachment of the 
conceptus to the endometrium. 
 
3.1 Hormonal regulation of the bovine oestrous cycle 
Throughout the oestrous cycle the endometrium features numerous functional and 
morphological changes. The length of the cycle is normally 21 days and is controlled by the 
ovarian sex steroid hormones, oestrogen and progesterone. Other important factors in 
regulation of the oestrous cycle are prostaglandins mainly the luteolysin prostaglandin F2 
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alpha (PGF2α), which is produced in the endometrial luminal and superficial glandular 
epithelium (GE) (Spencer, Johnson et al.). 
At oestrus (day 0), oestrogen levels peak from the oestrogen-producing dominant follicle 
resulting in increased ribosomal RNA and DNA synthesis and cell proliferation (Jackson and 
Chalkley 1974) via an increase in uterine estrogen receptor alpha (ESR1), progesterone 
receptor (PGR), and oxytocin receptor (OXTR) expression (Spencer, Johnson et al.). 
Furthermore, oestradiol increases blood circulation and oedematisation of the mucosa, and 
the smooth musculature shows high contractility. The highly cuboidal endometrial epithelium 
consists of both ciliated and secretory cells, the latter producing oestral mucus. The uterine 
glands are elongated as a result of the mucosal oedematisation (Ruesse and Sinowatz 
1998). In addition, oestradiol causes a rapid and high increase of luteinising hormone (LH) 
(Kesner, Padmanabhan et al. 1982), which in turn is necessary for ovulation and formation of 
the ovarian corpus luteum (CL) (Duffy, Crowe et al. 2000). 
During the three days period of metoestrus, oestradiol levels decrease continuously. 
Following ovulation progesterone levels slowly increase and the progesterone from the newly 
formed CL stimulates accumulation of phospholipids in the luminal and superficial glandular 
epithelium that can liberate arachidonic acid for synthesis and secretion of PGF2α (Spencer, 
Johnson et al.). This phase is additionally characterised by low levels of both progesterone 
and oestradiol in the peripheral blood. Mucosal oedema and contractility of the smooth 
musculature are declining during metoestrus. 
In dioestrus the surface epithelial cells are flat and the highly active and proliferating uterine 
glands secrete uterine milk, also called histotroph (Ruesse and Sinowatz 1998). 
Progesterone levels are highest and act via PGR to block expression of ESR1 and OXTR in 
the endometrium (Spencer, Johnson et al.). The mature CL produces oxytocin, too. During 
late dioestrus (from day 15 of the oestrous cycle) progesterone causes the downregulation of 
its own receptor in the LE and the GE. In consequence, expression of OXTR and ESR1 
rises. Binding of oxytocin to its receptor initiates the pulsatile secretion of PGF2α. PGF2α is 
produced from membrane phospholipids by phospholipase A2, cyclooxygenase, and 
prostaglandin F2α synthase and is in addition to the regulation of other processes, such as 
ovulation, implantation and parturition, responsible for luteolysis (Goff 2004; Silvia, Lewis et 
al. 1991). The functional and structural regression of the CL leads to the decrease of P4 
levels. Growing follicles on the ovary release estrogens, resulting in the production of 
pituitary follicle-stimulating hormone (Hewitt, Deroo et al.) (Kesner, Padmanabhan et al. 
1982). FSH stimulates one follicle to growth over a certain extent and to become the 
dominant follicle for the next ovulation, which produces oestradiol and is responsible for the 
LH surge before ovulation. 
 
 6 
3.1.1 Progesterone 
In all mammals progesterone plays an important role in the regulation of the oestrous cycle 
and acts via the progesterone receptor (PGR), which is expressed in the endometrial 
epithelium and stroma during the early luteal phase, allowing direct regulation of a number of 
genes. Progesterone has been shown to be a very important factor for the establishment and 
maintenance of pregnancy, due to its critical role for conceptus survival and development by 
orchestrating the biochemical interactions between the embryo and the endometrium. 
Implantation in cattle starts at the end of dioestrus from day 18 or 19 on. The progesterone-
dominated pre-implantation period from blastocyst formation until successful maternal 
recognition of pregnancy is a very interesting and sensible phase, because up to 40% of total 
embryonic losses in cattle occur between days 8 and 17 of pregnancy. This early embryonic 
mortality is the main source of reproductive wastage (Humblot 2001) and results from failures 
during the development of the early embryo or insufficient supply of the embryo by the 
endometrium. In this phase the hatching and elongation of the blastocyst proceeds as it 
undergoes dramatic changes in size and morphology (Spencer and Bazer 2002). 
High concentrations of P4 from days 2 to 5 enhance conceptus development and size on day 
14 in heifers (Garrett, Geisert et al. 1988), while animals with low concentrations in the early 
luteal phase have retarded embryonic development in ruminants (Mann and Lamming 2001; 
Nephew, McClure et al. 1991) and decreased production of interferon tau (IFNT), the signal 
for establishment of pregnancy, from bovine conceptuses (Mann and Lamming 2001). Both 
in lactating dairy cows and in heifers, there is a strong positive correlation between early 
luteal phase plasma progesterone concentrations and embryonic survival rate (Larson, Butler 
et al. 1997; Starbuck, Darwash et al. 1997; Villa-Godoy, Hughes et al. 1988). 
The direct action of progesterone on the uterus is important for the regulation of a number of 
physiological systems: the endometrial luteolytic signal via prostaglandin F2α (PGF2α) 
synthesis; maternal recognition of pregnancy whereby the conceptus produces IFNT that 
acts on the endometrium to prevent the luteolytic cascade; and the expression of the 
appropriate genes responsible for the uterine production of specific proteins, growth factors 
and modulators of immune functions necessary for conceptus growth and development 
(Spencer, Johnson et al. 2004). 
A number of genes in the rodent, human, and primate uterus are already known to be directly 
regulated by progesterone, including transcription factors (runt-related transcription factor 2), 
growth factors (epidermal growth factor), binding proteins (insulin-like growth factor binding 
proteins), homeobox genes (HOXA10 and HOXA11), morphogens (Indian hedgehog 
homolog), enzymes (histidine decarboxylase), protease inhibitors (serine peptidase inhibitor, 
Kazal type 3), peptide hormones (proenkephalin; calcitonin), biogenic amines (histamine), 
and adhesion proteins (immunoresponsive gene 1) (Spencer, Johnson et al.). 
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One example for an important pathway regulated by progesterone is the Wnt signalling 
pathway. In human endometrium dickkopf 1 (DKK1) and other inhibitors of Wnt signalling are 
markedly upregulated during the progesterone dominated ‘window of implantation’. In 
contrast, secreted frizzled-related protein 4 (SFRP4), another inhibitor, is down-regulated. 
Presumably the Wnt family plays a role in epithelial-embryo and/or epithelial-stromal 
interactions and thus in uterine receptivity (Kao, Tulac et al. 2002). 
 
3.1.2 Oestradiol 
The steroid hormone 17β-oestradiol is involved in the development of the reproductive tract 
and the mammary gland, regulates the oestrous cycle, and controls lactation (Watanabe, 
Suzuki et al. 2003). The effect of oestradiol on the uterus is dependent on P4, because it is 
only observed after the endometrium has been primed with P4 for a certain period of time 
(Goff 2004). Retinoids, especially all-trans retinoic acid (RA), suppress oestrogen-dependent 
proliferation of mammary gland and endometrial cells (Deng, Shipley et al. 2003). The 
number of oestrogen receptors (ESR1) increases at the end of the luteal phase in the bovine 
endometrium, due to the loss of PGR expression in the LE and GE and induction by 
oestradiol (Goff 2004). This increase causes several physiological and biochemical 
responses, which have been divided into events that occur early, within the first hours after 
oestradiol elevation, and subsequent responses that follow up to 24 h after the oestradiol 
peak. Early events are e.g. hyperaemia and infiltration of immune cells such as macrophages 
and eosinophiles. Genes involved in these processes are for example genes which are 
known to be induced by growth factors like early growth response 1 (EGR1) or polo-like 
kinase 2 (PLK2) (Watanabe, Suzuki et al. 2003). Later phase responses include an increase 
in uterine wet weight, the development of the epithelial layer into columnar secretory 
epithelial cells, and subsequent mitosis. Further known oestradiol-regulated genes found in a 
study in mice are involved in chromatin structure or modification (histone cluster 2, H2ac 
(HIST2H2AC), histone deacetylase 5 (HDAC5)), in keratinisation or cornification (small 
proline-rich protein 1A and 2A, stratifin) or apoptosis associated (BCL2-antagonist of cell 
death, v-akt murine thymoma viral oncogene homolog 1) (Hewitt, Deroo et al. 2003).  
An important pathway regulated by oestradiol is the transforming growth factor beta (TGFB) 
pathway. In mammals, three isoforms of TFGB (TGFB1, 2, and 3) have been identified. 
TGFBs are multifunctional cytokines that influence numerous cellular processes. They can 
regulate cell proliferation and differentiation positively or negatively depending on cell type 
and have been implicated in diverse physiological events such as angiogenesis, immune 
function, steroidogenesis, and tissue remodelling and repair. The regulation of TGFB differs 
between species. In women, TGFB expression is upregulated during times of increasing 
plasma progesterone concentrations whereas in rodents and ewes oestradiol increases the 
endometrial expression of mRNAs encoding TGFB. The high expression rate in late 
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dioestrus and pro-oestrus reported in rats and ewes may indicate a role for these growth 
factors in the restructuring of the endometrium that occurs during the transition from one 
cycle to the next. The TGFBs are recognized to regulate cellular processes through their 
stimulatory action on extracellular matrix (ECM) formation, cellular matrix binding receptors 
and increased synthesis of protease inhibitors and repression of proteases that degrade 
ECM. During pregnancy uterine TGFBs are involved in processes like apoptosis, trophoblast 
attachment, growth, differentiation, immunotolerance, cytokine and hormone production and 
embryogenesis (Godkin and Dore 1998). 
 
3.2 Global gene expression studies during the female sexual cycle 
The endometrium is a uniquely dynamic tissue, with the capacity to undergo dramatic 
remodelling in response to cyclic variations in steroid hormones and local autocrine and 
paracrine factors. The mRNA content of each of its different cell types is altered during 
different phases of the sexual cycle, with the onset of implantation, as well as in pathological 
conditions. In human e.g. abnormal menstruation, infections or cancer are known to cause 
pathological changes in gene expression. Gene expression profiling has the capacity to 
identify new targets for the manipulation of fertility and the diagnosis and treatment of 
endometrial abnormalities (White and Salamonsen 2005).  
Several microarray studies have been performed to obtain detailed knowledge about the 
gene expression changes during the physiological female sexual cycle. In humans, several 
studies were done investigating gene expression changes occurring in the endometrium 
during the menstrual cycle. Two studies using commercially available microarrays compared 
gene expression differences between the early secretory phase (2-4 days after LH-surge) 
and the mid-luteal phase (days 7-9 after LH-surge) (Borthwick, Charnock-Jones et al. 2003; 
Martin, Dominguez et al. 2002; Riesewijk, Martin et al. 2003). Riesewijk et al. identified 211 
regulated genes, 153 were up-regulated at LH+7 versus LH+2, whereas 58 were down-
regulated. In addition to genes with already known roles in human endometrial receptivity, 
the authors found among others genes coding for enzymes, cell cycle-associated proteins 
and membrane proteins (Borthwick, Charnock-Jones et al. 2003; Martin, Dominguez et al. 
2002; Riesewijk, Martin et al. 2003). A study by Borthwick and co-workers identified 149 
transcripts with significant differences between the proliferative and the secretory phase of 
the human menstrual cycle. Among the differential expressed transcripts more than 100 
known genes could be subdivided into functional families like transcription factors, cell death 
and survival factors, transport and carrier proteins and differentiation and embryonic polarity 
mediators such as members of the Wnt family. Among the remaining transcripts, which were 
not yet described as related to endometrial functions a number of novel factors were 
discovered. Examples for these new factors are trefoil factor 3 (TFF3) and glutathione 
peroxidise 3 (GPX3) (Borthwick, Charnock-Jones et al. 2003; Martin, Dominguez et al. 2002; 
 9 
Riesewijk, Martin et al. 2003). Endometrial gene expression during the proliferative phase 
versus the secretory phase of the sexual cycle was also compared in the rhesus monkey 
(Ace and Okulicz 2004) and in the mouse (Tan, Li et al. 2003). In the endometrium of rhesus 
monkeys 108 genes were found as significantly regulated. Of these genes 39 were up-
regulated at days 21-23 versus day 13, and 69 were down-regulated. The up-regulated 
genes encode immune-related proteins, cytokines, histones, cell-cycle-regulation proteins, 
and cell growth inhibitors. The down-regulated genes belong to different functional groups 
including cell adhesion, extracellular matrix components and inhibitors of Wnt signalling (Ace 
and Okulicz 2004). Tan et al. compared gene expression profiles of murine endometrium at 
oestrus versus dioestrus stage. They identified 51 up-regulated and 51 down-regulated 
genes at oestrus. Most of the up-regulated genes encode secreted immune-related proteins, 
proteinases and their inhibitors, indicating their potential involvement in sperm viability as 
well as capacitation. The down-regulated genes mainly encode cell cycle-related factors, 
reflecting the active proliferation of the endometrium at dioestrus (Tan, Li et al. 2003). Peter 
Rogers group was the first that collected biopsy samples of human endometrium to specify 
stages of the cycle based on mRNA expression profiles (Ponnampalam, Weston et al. 2004). 
Talbi et al. (Talbi, Hamilton et al. 2006) used a similar approach to characterise human 
endometrial biopsies of unknown cycle stage. To identify genes regulated by oestrogens, 
Andrade and co-workers (Andrade, Silva et al. 2002) treated ovariectomised virgin rats either 
with conjugated equine oestrogens or placebo and compared endometrial mRNA profiles. 
Genes regulated by P4 in the ovine uterus resulted from a study with uterine gland knockout 
ewes (Gray, Abbey et al. 2006). 
Bauersachs and co-workers extracted epithelial cells from the bovine oviduct and compared 
gene expression profiles from the ipsilateral oviduct at oestrus and dioestrus (Bauersachs, 
Rehfeld et al. 2004). Furthermore they performed a screen of transcriptome changes in 
bovine intercaruncular endometrium at day 0 (oestrus) and day 12 (dioestrus) of the oestrous 
cycle. Using a combination of subtracted cDNA libraries and cDNA array hybridisation 133 
genes were identified, 65 with higher levels at oestrus and 68 at dioestrus. Genes 
upregulated at oestrus were assigned to Gene Ontology categories like focal adhesion 
formation, cell motility, cytoskeleton, extracellular matrix, and cell growth. At dioestrus 
elevated concentrations of mRNAs coding for a variety of metabolic and transporter proteins 
were identified. Based on searches in pathway databases and the literature several 
physiological processes and signalling cascades were obtained, e.g. the TGFB signalling 
pathway and retinoic acid signalling, which are potentially involved in the regulation of 
changes of the endometrium during the oestrous cycle. Fourteen genes upregulated at 
oestrus and three genes upregulated at dioestrus were assigned to the TGFB signalling 
pathway. Target genes of this signalling pathway (collagens, FBLN1, FBLN5, FN1) and 
inhibitors of TGFB signalling (DCN, THBS1, INHBA, HTRA1) were found at oestrus. At 
dioestrus, two of the identified genes also have been shown to have inhibitory functions 
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(MGP, TDGF1). From the retinoic acid (RA) signalling pathway, which is supposed to play a 
role in the regulation of the endometrial differentiation state, several involved genes were 
identified (oestrus: LGALS1, RARRES1, SERPINH1; dioestrus: CYP26A1, RARRES2, 
RDHE2, TGM2). The results of this study were also compared with microarray studies done 
in other species. An overlap of 34 genes was found where about half of the mRNA 
expression changes for these genes were in the same direction. The relative small overlap 
particularly with the human studies is in line with the distinct differences in the cycle 
(oestrous cycle lesser changes than during menstrual cycle) and in the type of implantation 
of the embryo (invasive versus non-invasive implantation) (Bauersachs, Ulbrich et al. 2005). 
Other studies of this group were focused on transcriptome changes in the endometrium 
during the pre-implantation phase. Day 18 of pregnancy has been analysed using two 
different experimental models: i) a comparison of pregnant vs. control endometrium derived 
from monocygotic twin cows where one twin received an embryo transfer and the 
corresponding twin a sham transfer and ii) a comparison of endometrium derived from 
heifers after artificial insemination vs. sham insemination (Bauersachs, Ulbrich et al. 2006; 
Klein, Bauersachs et al. 2006). Many of the resulting genes are known to be induced by 
interferon tau, the embryonic pregnancy recognition signal. Based on the identified genes a 
first model of biological processes and corresponding genes important for embryo 
implantation and establishment of pregnancy was drawn.  
But among all these studies that analysed gene expression changes during the physiological 
female sexual cycle there was no systematic large-scale gene expression study comparing 
more than two stages of the cycle. In Publication 2 the custom made cDNA array (BOE 
array) described in Publication 1 was used for the generation of mRNA expression profiles of 
bovine endometrium samples derived from several stages of the oestrous cycle: oestrus (day 
0), metoestrus (day 3.5), dioestrus (day 12), late dioestrus (slaughtered at day 18, high 
serum progesterone levels), and preoestrus (slaughtered at day 18, low serum progesterone 
levels). 
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During the oestrous cycle, the bovine endometrium exhibits characteristicmorphological and functional changes, which aremainly induced
by progesterone (P4), oestrogens and oxytocin. We studied the response of the endometrium to this changing hormonal environment at the
transcriptome level using a custom-made cDNA microarray. Endometrium samples were recovered from Simmental heifers on days 0
(oestrus), 3.5 (metoestrus), 12 (dioestrus) and 18. The latter group was divided into animals with high (late dioestrus) and low P4 levels
(preoestrus). Significance analysis of microarrays revealed 269 genes exhibiting significant changes in their transcript levels during the
oestrous cycle in distinct temporal patterns. Two major types of expression profiles were observed, which showed the highest mRNA levels
during theoestrusphaseor thehighest levels during the lutealphase respectively.Aminor groupof genes exhibited thehighestmRNAlevels on
day 3.5. Gene ontology (GO) analyses revealed GO categories related to extracellular matrix remodelling, transport, and cell growth and
morphogenesis enriched at oestrus, whereas immune response and particular metabolic pathways were overrepresented at dioestrus.
Generationofgene interactionnetworksuncovered thegenespossibly involved inendometrial remodelling (e.g. collagengenes,TNC,SPARC,
MMP2,MEP1B, TIMP1, TIMP2, HTRA1), regulation of angiogenesis (e.g. ANGPTL2, TEK, NPY, AGT, EPAS1, KLF5 ), regulation of invasive
growth (e.g. PCSK5, tight junction proteins, GRP, LGALS1, ANXA2, NOV, PLAT,MET, TDGF1, CST6, ITGB4), cell adhesion (e.g.MUC16,
LGALS3BP ) andembryo feeding (e.g.SLC1A1,SLC11A2,SLC16A1,SEPP1,ENPP1). LocalisationofmRNAexpression in theendometriumwas
analysed for CLDN4, CLDN10, TJP1, PCSK5,MAGED1, and LGALS1.
Reproduction (2008) 135 225–240Introduction
Throughout the oestrous cycle and during pregnancy, the
bovine endometrium exhibits characteristic morpho-
logical and functional changes, which are mainly
regulated by progesterone (P4), oestrogens and oxytocin
(Spencer et al. 2004b). With respect to the typicalThis article was presented at the 2nd International Meeting on
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Research Programme: Biological Resource Management for Sustain-
able Agricultural Systems of The Organisation for Economic Co-
operation and Development (OECD) has supported the publication of
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de-France, the Institut National de la Recherche Agronomique (INRA),
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ISSN 1470–1626 (paper) 1741–7899 (online)characteristics of the endometrial structure and function,
the bovine oestrous cycle can be divided into four stages:
preoestrus,oestrus,metoestrus and dioestrus.Atoestrus, P4
levels are low, whereas oestrogens are elevated. This leads
to increased blood circulation and oedematisation of the
mucosa and to a high contractility of the smooth
musculature. The highly cuboidal endometrial epithelium
consists of both ciliated cells and secretory cells, which
produceoestralmucus.The uterineglandsareelongated as
a result of the mucosal oedema (Ruesse & Sinowatz 1998).
Oestradiol levels start to decrease just before the
luteinising hormone (LH) surge and ovulation. Following
ovulation, P4 levels increase during the 3-day period of
metoestrus due to the formation of the new corpus luteum.
This phase is characterised by low levels of both P4 and
oestradiol in the peripheral blood. Mucosal oedema andDOI: 10.1530/REP-07-0415
Online version via www.reproduction-online.org
226 K Mitko and otherscontractility of the smooth musculature are declining
during metoestrus. During dioestrus, there are high P4 and
low oestradiol levels and the surface epithelial cells are
flat. The highly active and proliferating uterine glands
secrete uterine milk or histotroph. Its best characterised
constituent is uteroferrin, an iron-containing acidic
phosphatase, which is involved in the transport of iron to
the conceptus. A group of basic protease inhibitors, which
have considerable sequence homology to bovine
pancreatic trypsin inhibitor (aprotinin), are supposed to
control intrauterine proteolytic events initiated by the
conceptus. Another secreted basic protein is lysozyme,
which is presumed to have an antibacterial effect (Roberts
& Bazer 1988). If no embryo is present, luteolytic pulses of
prostaglandin F2a (PGF2a) lead to the regression of the
ovarian corpus luteum after day 18 resulting in a strong
decrease in P4 during preoestrus and the entry into a new
ovarian cycle (Goff 2004). In contrast, during early
pregnancy, the bovine embryo produces interferon-t
(IFNT) asmain anti-luteolytic pregnancy recognition signal
that prevents luteolysis and the corpus luteum continues
production of P4 as a prerequisite for further development
and implantation of the conceptus (Spencer et al. 2004a).
There are a number of studies using microarrays for the
investigation of gene expression changes in the endome-
trium during the sexual cycle in humans (Horcajadas
et al. 2007), rhesus monkeys (Ace & Okulicz 2004) and
mice (Tan et al. 2003). Furthermore, in a first tran-
scriptome study of bovine endometrium during the
oestrous cycle, more than 130 genes have been
identified as differentially expressed between oestrus
and dioestrus (Bauersachs et al. 2005). P4-induced genes
have been characterised in sheep endometrium in a
study where cyclic ewes were treated with P4 and endo-
metrial tissue samples were analysed using a custom
ovine cDNA array (Gray et al. 2006). However, there are
no systematic large-scale gene expression studies
comparing more than two stages of the sexual cycle.
Only recently, human endometrial biopsy samples were
collected during the cycle and analysed in a microarray
study with the objective to assign the samples to specific
stages of the cycle based on their relative mRNA
expression profiles (Ponnampalam et al. 2004).
In the present study, a custom-made bovine oviduct
and endometrium (BOE) cDNA array (Bauersachs et al.
2007) was used to generate mRNA expression profiles of
the bovine endometrium during the oestrous cycle.
Molecular pathways were identified as related to the
biological functions of the endometrium in the context of
recognition and establishment of early pregnancy.Results
The animals slaughtered during the oestrous cycle were
subdivided intofive groups, each with fouranimals: days0,
3.5, 12 and 18 with high P4 levels (O2.8 ng/ml; 18P4H),
and day 18 with low P4 levels (!0.7 ng/ml; 18P4L). ToReproduction (2008) 135 225–240analyse gene expression changes in the bovine intercar-
uncular endometrium during the oestrus cycle at the level
of the mRNA, a custom-made cDNA array (BOE array) was
used (Bauersachs et al. 2007). This array contains 1344
cDNA fragments and 96 oligonucleotides representing
950 different genes. Most of them were identified as
differentially expressed in the endometrium during early
pregnancy and the oestrous cycle and in oviduct epithelial
cells in several previous studies (Bauersachs et al. 2003,
2004, 2005, 2006, Klein et al. 2006). RNA of the
intercaruncular endometrial tissue samples, derived from
the middle part of the ipsilateral uterine horn, was used for
the preparation of 33P-labelled probes. In total, 20 BOE
arrays were hybridised and evaluated. Quality control
(distance matrix and heatmap; BioConductor package
geneplotter) of normalised data revealed one hybridisation
as an outlier leading to the exclusion of one day 12 sample
from the analyses of microarray results. For the identifi-
cation of mRNAs with significant changes of their
concentration in the endometrium during the oestrous
cycle, normalised data were analysed with the ‘signi-
ficance analysis of microarrays method (SAM, Multiclass,
false discovery rate (FDR) 1%; Tusher et al. 2001).
This analysis revealed 427 cDNA fragments or
oligonucleotides with significant changes of hybrid-
isation signals during the oestrous cycle. These fragments
corresponded to 269 different genes, 267 of them with
known or inferred function (Supplementary Table 1,
which can be viewed online at www.reproduction-
online.org/supplemental). For some cDNAs, no bovine
mRNA sequence was found in the GenBank, but the
putative human orthologous gene was identified. Two
cDNAs could not be assigned to any sequence in the
GenBank database and to the bovine genome sequence.
Data from the significant genes were used for cluster
analyses. First, data of 19 samples were clustered
according to the genes and samples to characterise
the differences between the analysed stages of the cycle
(Supplementary Figure 1, which can be viewed online
at www.reproduction-online.org/supplemental). The
samples clustered in three major groups, consisting of
day 0 and day 18P4L (Supplementary Figure 1, left), day
3.5 (middle) and day 12 and day 18P4H animals (right)
respectively. The third group split into two subgroups
corresponding to the day 12 and day 18P4H animals. The
day 18P4L and day 0 animals did not split into two distinct
separate groups. A two-class SAM analysis for days 0 and
18P4L revealed only two transcripts, which were signi-
ficantly more abundant in the 18P4L animals. The cluster
analysis in Supplementary Figure 1 shows that the greatest
difference is present between the animals of the oestrous
(days 18P4L and 0) and dioestrus stages (day 12).
For the identification of groups of genes showing similar
dynamic patterns in their expression levels during the
oestrous cycle, a second cluster analysis was performed.
Different numbers of clusters from five to ten were tested
and the number of seven clusters was found best towww.reproduction-online.org
Figure 1 Clusters of similar expression
profiles during the oestrous cycle.
Genes were clustered according to the
correlation of their expression profiles
during the oestrous cycle using self-
organising tree algorithm (SOTA,
MultiExperiment Viewer 4.0). The
SOTA dendrogram (bottom right)
shows the similarity between clusters.
Expression profiling of bovine endometrium 227represent similar expression profiles (Fig. 1). In the first
cluster (80 genes), the mRNA levels are low at oestrus (days
18P4L and 0) and metoestrus (day 3.5) and rise on day 12
(dioestrus). Cluster 1 also contains a number of genes with
increasing mRNA levels from days 12 to 18P4H but a two-
class SAM analysis between the groups, days 12 and
18P4H, revealed almost no significantly higher signals at
day 18P4H compared with day 12. In the second cluster
(76 genes), the mRNA levels are also low at oestrus (days
18P4L and 0) but are already increased on day 3.5. Clusters
3 (26 genes), 4 (23 genes) and 5 (37 genes) have all their
highest expression levels at days 18P4L and 0 (oestrus
stage). Cluster 3 differs from 4 and 5 therein that the mRNA
levels are decreased at days 3.5, 12 and 18P4H with the
lowest levels at day 3.5. Clusters 4 and 5 look quite similar,
but incluster 4 mRNA levels are lowerat day 3.5 compared
with cluster 5 and start to increase at day 18P4H. Cluster 6
(15 genes) contains genes that have higher mRNA levels
from days 18P4L to 3.5 (oestrus to metoestrus) and low
levels at days 12 and 18P4H. Cluster 7 consists of 12 genes
with the highest mRNA levels at day 3.5. However, some
genes, which have also their highest expression at day 3.5,
were assigned to the second cluster since – in contrast to
cluster 7 – their mRNA concentrations are higher at
dioestrus compared with oestrus.
Ninety-four of the genes showed their highest mRNA
expression level in the groups, days 18P4L and 0; 23 genes
at day 3.5; 112 genes atday 12; and 40 genesatday 18P4H.
The results of the cDNA array hybridisation were
verified and absolutely quantified by the use ofwww.reproduction-online.orgquantitative real-time RT-PCR (qPCR). The same RNA
samples as for the array hybridisation were used. Eleven
genes were selected for the validation of different types of
mRNA expression profiles revealed by the microarray
analysis. Furthermore, most of the genes were chosen due
to their proposed functions in the context of maternal
fertility and establishment of pregnancy. Table 1 shows
the relative expression data obtained by qPCR and the
corresponding array data. The table shows mean fold
changes between various stages of the oestrous cycle
when compared with the stage with the lowest expression
(set to 1.0). Array and qPCR data correlated well.
However, two of the analysed mRNAs showed no
significant (P!0.05) changes according to the qPCR.
For the analysis of gene ontology (GO) classifications
and pathway analyses, clusters 1 and 2 (high expression
levels at dioestrus) and clusters 3, 4, 5 and 6 (high
expression levels at oestrus) were combined respectively.
Enriched and underrepresented GO categories (signi-
ficance threshold: R3 genes, P%0.01) were identified
using GO tree machine (GOTM) and OntoExpress
respectively. Analyses were done based on Entrez Gene
IDs of the putative human orthologous genes. Redundant
and unspecific categories were removed. Enriched GO
categories for genes with higher expression at oestrus are
shown in Table 2. GO categories related to extracellular
matrix (ECM) remodelling (e.g. ‘collagen’, ‘extracellular
region’, ‘ECM’), transport processes (e.g. ‘transport’,
‘intracellular transport’, ‘establishment of protein localisa-
tion’, ‘endoplasmic reticulum’, ‘cytoskeleton-dependentReproduction (2008) 135 225–240
Table 1 Validation of array results using real-time RT-PCR.
Gene Gene name Analysis Day 18P4L Day 0 Day 3.5 Day 12 Day 18P4H P value*
CLDN10 Claudin 10 Array 14.1 14.8 7.2 1.3 1.0 !0.001
qPCR 28.3 33.9 13.0 1.2 1.0 !0.001
IRF1 Interferon regulatory factor 1 Array 1.5 1.0 2.0 2.5 3.4 0.001
qPCR 1.3 1.0 1.3 1.2 2.0 0.064
LGALS1 Galectin-1 Array 2.6 4.0 2.1 1.1 1.0 !0.001
qPCR 3.2 5.2 2.0 1.1 1.0 !0.001
PLA2G10 Phospholipase A2, group X
(secreted phospholipase A2)
Array 2.4 1.0 2.1 8.1 3.9 !0.001
qPCR 2.2 1.0 3.5 5.3 9.7 !0.001
PFN1 Profilin 1 Array 2.2 2.5 1.3 1.0 1.6 0.002
qPCR 2.7 2.5 1.0 1.0 1.2 0.006
SERPING1 C1 inhibitor Array 1.9 1.0 1.9 5.8 4.0 !0.001
qPCR 1.5 1.0 1.7 2.0 3.6 0.008
STC1 Stanniocalcin 1 Array 3.3 3.4 1.0 1.3 1.8 0.001
qPCR 8.9 4.3 1.0 1.0 2.8 0.001
TDGF1 Teratocarcinoma-derived
growth factor 1 (Cripto-1)
Array 1.1 1.0 1.0 28.0 1.4 !0.001
qPCR 1.6 1.0 1.0 88.8 1.8 !0.001
TNC Tenascin C (hexabrachion) Array 10.3 11.8 4.9 1.0 1.7 !0.001
qPCR 27.0 46.8 14.1 1.0 2.3 !0.001
TJP1 Tight junction protein 1 (zona
occludens 1)
Array 1.5 1.0 2.9 3.5 2.2 0.002
qPCR 1.0 1.0 1.5 1.2 1.1 0.219
*P value for array data.
228 K Mitko and othersintracellular transport’), cell growth and morphogenesis
(e.g. ‘insulin-like growth factor (IGF) binding’, ‘regulation
of cell growth’, ‘cell morphogenesis’) and cell shape (e.g.
‘cytoskeleton organisation and biogenesis’, ‘cytoskeletal
part’, ‘actin filament’, ‘microtubule-based movement’)
were found. Table 3 shows enriched GO categories
for genes with higher mRNA levels at dioestrus. Overall,
less and completely different enriched categories were
found compared with oestrus. The majority of enriched
GO categories belonged to the term ‘response to
stimulus’, which comprises subcategories such as
‘immune response’, ‘response to chemical stimulus’,
‘B-cell-mediated immunity’ and ‘antigen processing andTable 2 Quantitatively enriched gene ontology (GO) categories for genes u
GO category Genes
Extracellular region 29
Transport 28
Extracellular matrix 13
Intracellular transport 13
Establishment of protein localisation 10
Endoplasmic reticulum 10
Cytoskeletal part 9
Regulation of cell growth 8
Cell morphogenesis 8
Cytoskeleton organisation and biogenesis 8
IGF binding 5
Cytoskeleton-dependent intracellular transport 5
Growth factor activity 5
Microtubule-based movement 4
Microsome 4
Protein disulphide isomerase activity 3
Actin filament 3
Neuropeptide signalling pathway 3
Positive regulation of I-kB kinase/NF-kB cascade 3
aOntoExpress. bGO tree machine.
Reproduction (2008) 135 225–240presentation of endogenous antigen’. Furthermore, a
number of distinct metabolism categories (e.g. ‘lipid
catabolism’, ‘xenobiotic metabolic process’, ‘mono-
oxygenase activity’, ‘TCA cycle’) were obtained. In
addition to the GO analysis, the KEGG pathway database
was searched for the identified genes. Genes with higher
mRNA levels at oestrus were assigned to 42 pathways and
those with higher expression levels at dioestrus to 103
pathways. Considering only pathways where at least two
genes were assigned, 14 were obtained at oestrus and 43 at
dioestrus. The highest numbers of genes with increased
mRNA levels at oestrus were assigned to the pathways
‘focal adhesion’ (nine genes), ‘cell communication’ (eightp-regulated at oestrus (day 0/day 18P4L).
P value Tool
!0.001 OntoExpra
!0.001 GOTMb
!0.001 GOTM
!0.001 GOTM
0.005 GOTM
0.008 OntoExpr
0.005 GOTM
!0.001 OntoExpr
0.001 GOTM
0.003 GOTM
!0.001 GOTM
!0.001 GOTM
0.004 OntoExpr
!0.001 OntoExpr
0.005 OntoExpr
!0.001 GOTM
0.001 GOTM
0.003 OntoExpr
0.005 OntoExpr
www.reproduction-online.org
Table 3 Quantitatively enriched gene ontology (GO) categories for genes up-regulated at dioestrus (day 12/day 18P4H).
GO category Genes P value Tool
Response to stimulus 45 !0.001 OntoExpra
Immune response 18 !0.001 OntoExpr
Response to chemical stimulus 12 0.005 OntoExpr
MAPKKK cascade 8 !0.001 OntoExpr
Lysosome 8 !0.001 GOTMb
Endopeptidase inhibitor activity 6 0.005 GOTM
Lipid catabolism 5 0.004 GOTM
Microsome 5 0.008 OntoExpr
Xenobiotic metabolic process 4 !0.001 OntoExpr
B-cell-mediated immunity 4 0.002 GOTM
Monooxygenase activity 4 0.006 OntoExpr
Oxygen and reactive oxygen species metabolic process 4 0.007 OntoExpr
Helicase activity 4 0.008 OntoExpr
Aromatic compound metabolic process 4 0.011 OntoExpr
Antigen processing and presentation of endogenous antigen 3 0.001 GOTM
Tricarboxylic acid cycle 3 0.002 GOTM
Mitochondrial matrix 3 0.005 OntoExpr
aOntoExpress. bGO tree machine.
Expression profiling of bovine endometrium 229genes), and ‘ECM–receptor interaction’ (eight genes). The
genes assigned to these pathways were almost identical
with six of them coding for collagens. Three tubulin genes
(TUBB, TUBA1, TUBA1B) were assigned to the gap
junction pathway. Pathways with the highest numbers of
assigned genes showing higher mRNA levels at dioestrus
were ‘focal adhesion’ (five genes) and with four assigned
genes respectively three metabolic pathways (‘citrate
cycle’, ‘reductive carboxylate cycle’, ‘starch and sucrose
metabolism’), ‘complement and coagulation cascades’
and ‘antigen processing and presentation’. Figure 2 shows
pathways that contain genes of both types of regulation.
The genes with elevated mRNA levels either at oestrus or
at dioestrus were further analysed with the ‘functional
annotation clustering’ tool of the Database for Annotation,
Visualization and Integrated Discovery (DAVID; Dennis
et al. 2003). The results of this integrated analysis of
different functional databases (e.g. GO, KEGG pathways,
SP-PIR keywords) are clusters of more or less enriched
members with overlapping sets of genes, thus resulting in a
significant cluster enrichment score (geometric mean inK
log scale of member’s Fisher exact P values in a
corresponding annotation cluster). An enrichment score
of 1.3 corresponds to a P value of 0.05. The results of this
analysis are summarised in Tables 4 and 5, where the most
informative terms, the number of genes assigned to the
cluster and the enrichment score of the cluster are shown.
At oestrus, most significant clusters are containing
members related to extracellular region, focal adhesion,
transport, morphogenesis, regulation of cell growth,
protein transport and cytoskeleton. At dioestrus, the
highest enrichment scores were found for response to
stimulus, immune response, glycoprotein, lysosome,
transcription factor activity and carbohydrate metabolism.
Using Pathway Architect software (version 2.0.1,
Stratagene, Heidelberg, Germany), interaction networks
were built for genes up-regulatedat oestrus (self-organising
tree algorithm, SOTA clusters 3, 4, 5, and 6 in Fig. 1) andwww.reproduction-online.orggenes up-regulated at dioestrus (SOTA clusters 1 and 2 in
Fig. 1) respectively. Networks were drawn based on the
different types of interactions like binding, regulation,
expression, transport, assignment to a protein family or a
biological process. Furthermore, interactions with small
molecules and proteins not regulated, but substantially
contributing to the network, were also included. Proteins
were assigned to their primary cellular localisation.
Figure 3 (see also Supplement to Figure 3, which is
available online at www.reproduction-online/supple-
mental/) shows the interaction network for the genes
with higher mRNA concentrations at oestrus, of which 67
could be assigned. In Fig. 4 (see also Supplement to
Figure 4, which is available online at www.reproduction-
online/supplemental/), the network of genes with elevated
mRNA levels at dioestrus (103 genes assigned) is shown.
For further details on the interactions and the genes, see the
supplemental material (navigable HTML files).
For six selected genes (claudin 10 (CLDN10), CLDN4,
galectin-1 (LGALS1), melanoma antigen family D, 1
(MAGED1), prohormone convertase 5 (PCSK5) and tight
junction protein 1 (TJP1)), in situ hybridisation with the
bovine endometrial tissue sections corresponding to those
used for microarray analyses was carried out (Fig. 5). These
six genes were selected due to their potential role in cell
adhesion and regulation of implantation. As revealed by
the array hybridisation, CLDN10, LGALS1, MAGED1 and
PCSK5 mRNAs showed the highest levels atoestrus,TJP1 at
day 12 and CLDN4 atday 18 (P4 high).A specific patternof
mRNA distribution in the endometrium was found for each
of these genes. The hybridisation signal was always
confined to the cells of the endometrium. No mRNA
staining was seen in the myometrium or the serosa. No
specific signalwasobserved in the sections hybridisedwith
the sense strand or in sections that were incubated with
buffer only instead of the oligoprobes. Table 6 summarises
the results of the mRNA localisation experiments.Reproduction (2008) 135 225–240
Figure 2 Results of KEGG pathway search. KEGG pathways were
searched for the differentially expressed genes. Pathways containing
both genes with the highest mRNA levels at oestrus and genes with the
highest mRNA levels at dioestrus are shown. Grey boxes, genes
up-regulated at oestrus; black boxes, genes up-regulated at dioestrus.
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After an initial investigation of the differential gene
expression in the bovine endometrium between the
oestrus and dioestrus stages in our previous study
(Bauersachs et al. 2005), the present work provides the
first study of dynamic changes in the mRNA expression
profiles between several time points of the oestrous
cycle. As in our earlier studies, the intercaruncular
endometrium was used for gene expression analyses,
since there are distinct differences between the carun-
cular and intercaruncular endometrium regarding
morphology and function. Most notably, the caruncles
contain no uterine glands. After embryo implantation,
the caruncles grow rapidly and form individual
placentomes, which are responsible for gaseous and
small molecule exchange. Because the uterine glands
play an important role in the supply of large molecules to
the embryo before and after implantation (Atkinson et al.
1984), the intercaruncular tissue samples were preferred
for gene expression analyses.
For the oestrous stage, two groups of samples were
collected corresponding to early oestrus (around oestra-
diol peak) and late oestrus (after LH surge). Furthermore,
the early luteal phase, the dioestrus phase and the late
luteal phase were included. The latter cycle stage was
analysed because the implantation of the bovine embryo
is initiated at day 18, which requires appropriate
conditioning of the endometrium (Bauersachs et al.
2006, Klein et al. 2006).
The statistical analysis of themicroarraydataaswell as the
hierarchical clustering hardly showed any significant
differences between the early (18P4L) and the late oestrus
samples (day 0). Either no major differences in the mRNA
levels between the early and late oestrus exist or the day 0
and day 18P4L groups were not homogeneous enough
regarding their hormone levels to detect significant
differences in the endometrial transcriptome profiles. Inter-
individual variation is clearlyan important issue, sincegenes
like TGFB1 (transforming growth factor b1) show only
transient mRNA up-regulation for a few hours after
oestrogen induction (Takahashi et al. 1994). The most
pronounced differences were found between the oestrus
and dioestrus stages. The gene expression at day 3.5 is an
intermediate between oestrus and dioestrus for most of the
analysed genes either increasing or decreasing during the
luteal phase. In addition to the marked differences between
oestrus and dioestrus, significant differences were found
between the mid- and late luteal phase with the mRNA
levels mainly decreasing during the late luteal phase in
correlation with lower P4 levels in the day 18P4H group
compared with the day 12 group.
The analysis of GO categories, KEGG pathways and
functional annotation clustering revealed quantitatively
enriched biological processes and molecular functions,
which are distinct for the ovulatory and the luteal phases.
In accordance with our previous results (Bauersachs et al.www.reproduction-online.org
Table 4 Results of functional annotation clustering for genes with higher mRNA levels at oestrus.
Cluster description Genes Score
Signal peptide/glycoprotein/extracellular region 40 6.13
Structural molecule activity/extracellular matrix/coiled coil/focal adhesion/cell communication 38 4.09
Morphogenesis/regulation of cell growth/IGF binding 12 3.74
Cytoplasm/transport 40 2.41
Acetylation/cytoskeleton/cytoskeletal protein binding 18 2.04
Transporter activity/generation of precursor metabolites and energy/thioredoxin fold/protein disulphide
isomerase activity
12 2.01
Establishment of protein localisation/endoplasmic reticulum 13 1.80
Cell organisation and biogenesis/purine nucleotide binding/cytoskeleton/hydrolase activity 39 1.71
Cell motility 5 1.32
G-protein-coupled receptor protein signalling pathway/neuropeptide 5 1.23
Expression profiling of bovine endometrium 2312005), a number of mRNAs coding for the ECM proteins
and the components of the cytoskeleton were found as
enriched at oestrus, indicating a remodelling of the ECM
in the endometrium and changes of the cytoskeleton of
endometrial cells. The lower mRNA levels of collagen
genes at dioestrus are in line with the results of a recent
study (Yamada et al. 2002) where a decrease in collagen
fibres has been observed during the pre-implantation
phase in the bovine endometrium. This also fits well with
the expression profiles of MMP2 (SOTA cluster 2) and
MEP1B (SOTA cluster 1) mRNAs coding for proteases
involved in the ECM degradation (Kaushal et al. 1994).
MEP1B mRNA showed the highest levels at days 12 and
18. The MMP2 mRNA expression profile was not typical
for cluster 2, since concentration was the highest at day
3.5 and low at all other analysed time points. The
expression profiles of TIMP1 (cluster 3) and TIMP2
(cluster 1) mRNAs, coding for inhibitors of matrix
metalloproteinases, were opposite to MMP2 with the
lowest levels at day 3.5. The mRNA levels of most
collagen genes and other constituents of the ECM were
similar from days 18P4L to 3.5 and low at days 12 and 18
(clusters 5 and 6). HTRA1 mRNA codes for a serine
protease that is activated by C-propeptides of fibrillar
collagens (Murwantoko et al. 2004) and has been shown
to cleave TGFB1 and other members of the TGFB family
(Oka et al. 2004). The mRNA expression profile (cluster 6)
was similar to those of fibrillar collagens. In addition, the
expression of HTRA1 has been shown in the human
placenta at the maternal–trophoblast interface (Nie et al.
2006). The mRNA expression profiles of all these genesTable 5 Results of functional annotation clustering for genes with higher m
Cluster description
Response to stimulus/immune response
Glycoprotein/signal peptide
Vacuole/lysosome
Humoral immune response/complement and coagulation cascades
Transcription factor activity/interferon regulatory factor
Catabolism/carbohydrate metabolism/TCA cycle
Response to chemical stimulus/endoplasmic reticulum/monooxygenase
Enzyme regulator activity/endopeptidase inhibitor activity
Immune response/antigen processing and presentation
Generation of precursor metabolites and energy/mitochondrion/TCA cycle
www.reproduction-online.orgsuggest a complex regulation of the ECM remodelling in
the bovine endometrium during the oestrous cycle.
Probably, in connection with increased ECM synthesis,
genes relevant for protein folding and secretion were
enriched at oestrus. For example, SERPINH1 (serpin
peptidase inhibitor, clade H, member 1), also known as
HSP47, has been described as collagen-binding protein
of the endoplasmic reticulum involved in collagen
processing and secretion (Nagata 1996). Furthermore,
transcripts of the genes related to the regulation of cell
growth were overrepresented at oestrus. These include
mRNAs of a number of IGF-binding proteins, which are
important for the regulation of cell growth. The interaction
network shows that theyare probably regulated by TGFB1,
retinoic acid (RA) and oestrogen in a complex manner.
Oestrogen may mediate a number of its effects on the
endometrium via induction of TGFB1 and RA. Direct
induction of expression of RA biosynthetic enzymes has
been found in the rat uterus (Li et al. 2004). In addition,
prostaglandin E2a (PGE2a), interferons (IFNG) and tumour
necrosis factor-a are suggested as important regulators by
the oestrus interaction network. A number of genes with
higher mRNA levels at oestrus were found in the context of
the process focal adhesion formation. Genes coding
for ECM proteins and components of the cytoskeleton,
which are linked via paxillin, are involved in this process.
A possible candidate for the regulation of cytoskeleton
proteins is polo-like kinase 2 (PLK2; SOTA cluster 5),
alsoknown as serum-inducible kinase SNK. PLK2 hasbeen
shown to play a role in the remodelling of synapses
via phosphorylation of spine-associated Rap guanosineRNA levels at dioestrus.
Genes Score
38 3.40
44 3.39
8 3.21
12 1.95
6 1.69
20 1.62
15 1.55
10 1.52
4 1.49
14 1.32
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Figure 3 Interaction network of genes with the highest mRNA levels at oestrus. Proteins (red) are assigned to their primary cellular localisations.
Proteins with higher mRNA levels at oestrus are highlighted in blue. Small molecules are in green and biological processes in yellow. Interaction
types: dark blue squares, binding; light blue squares, expression; green squares, regulation; green circles, promoter binding; orange circles, protein
modification; purple circles, member; green triangle, transport; cyan diamond, metabolism. Further information on nodes and interactions can be
found in Supplement to Fig. 3 (navigable HTML, which is available online at www.reproduction-online/supplemental/ ).
232 K Mitko and otherstriphosphatase-activating protein (SPAR), a postsynaptic
actin regulatory protein, leading to the degradation of
SPAR (Pak & Sheng 2003). PLK2 could play a similar role in
the modulation of actin filament polymerisation in the
bovine endometrium. A number of genes such as LGALS1,Reproduction (2008) 135 225–240tenascin C (TNC), osteonectin (SPARC), PCSK5, gastrin-
releasing peptide, annexin A2 and nephroblastoma
overexpressed gene; SOTA clusters 5, 5, 6, 4, 3, 5, 5)
have been described as positively involved in the
regulation of the process ‘invasive growth’. The decreasedwww.reproduction-online.org
Figure 4 Interaction network of genes with the highest mRNA levels at dioestrus. Proteins (red) are assigned to their primary cellular localisations.
Proteins with higher mRNA levels at dioestrus are highlighted in blue. Small molecules are in green and biological processes in yellow. Interaction
types: dark blue squares, binding; light blue squares, expression; green squares, regulation; green circles, promoter binding; orange circles, protein
modification; purple circles, member; green triangle, transport; cyan diamond, metabolism. Further information on nodes and interactions can be
found in Supplement to Fig. 4 (navigable HTML, which is available online at www.reproduction-online/supplemental/ ).
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Figure 5 Localisation of mRNA
expression of selected genes in the
endometrial tissue samples by in situ
hybridisation. Endometrial tissue
samples were obtained from animals
slaughtered at different days of
oestrous cycle for the detection of
CLDN10, LGALS1, MAGED1 and
PCSK5 mRNAs at oestrus (day 0) or
CLDN4 and TJP1 mRNAs at dioestrus
(days 18P4H and 12 respectively).
Endometrial sections (A) near the
epithelial surface, (B) of the deep
uterine glands and (C) the corres-
ponding sense controls are shown.
234 K Mitko and othersmRNA levels of these genes during the luteal phase may be
associated with the regulation of non-invasive implan-
tation in cattle. Furthermore, a couple of genes are
involved in the cell adhesion processes. Most importantly,
MUC16 mRNA is down-regulated during the luteal phase
(cluster 4). MUC16 protein has been shown to prevent
initial trophoblast cell adhesion and is lost in the humanReproduction (2008) 135 225–240endometrium during the receptive phase (Gipson et al.
2007).
It has been known for a long time that uterine blood
flow substantially changes during the oestrous cycle with
increased blood flow during oestrus (Greiss & Anderson
1969). In this context, a number of genes up-regulated at
oestrus are linked with the process angiogenesis in thewww.reproduction-online.org
Table 6 Localisation of mRNA expression of selected mRNAs in endometrial tissue samples by in situ hybridisation.
Glandular epithelium
Gene Gene name Luminal epithelium Superficial Deeper glands Stromal cells
CLDN10 Claudin 10 CC CC C (C)
CLDN4 Claudin 4 CC CCC C K
LGALS1 Galectin-1 C CC C (C)
MAGED1 Melanoma antigen family D, 1 (NRAGE) C C/CC (C) K
PCSK5 Prohormone convertase 5 C C (C) (C)
TJP Tight junction protein 1 (zona occludens 1) C/CC CC CCC (C)
K, no staining; (C), weak staining;C, moderate staining;CC, pronounced staining;CCC, strong staining.
Expression profiling of bovine endometrium 235interaction network. Some of them are known to directly
stimulate angiogenesis. ANGPTL2 (angiopoietin-like 2;
cluster 5) is related to the angiopoietins and has been
described to regulate endothelial cell growth (Morisada
et al. 2006). TEK (TEK tyrosine kinase, endothelial;
cluster 5) encodes the angiopoietin receptor TIE-2.
Neuropeptide Y (cluster 3) is a potent angiogenic factor
as well as a stimulator of vascular smooth muscle
proliferation (Abe et al. 2007).
For the genes up-regulated at dioestrus GO enrichment,
analyses revealed predominantly several immunological
processes like ‘immune response’, ‘response to stimulus’or
‘antigen processing and presentation’. Many of the
corresponding genes have been described as interferon
induced or were identified in our previous studies of
endometrium at day 18 of pregnancy (Bauersachs et al.
2006, Klein et al. 2006). This suggests that interferons
could also play a role in endometrial gene regulation
during the oestrous cycle or the corresponding genes are
additionally regulated through P4 effects. However, in a
study of porcine endometrium, lymphocytes and other
immune cells have been shown to immigrate into the
endometrium during dioestrus (Kaeoket et al. 2001). In the
interaction networkof the luteal stage of theoestrouscycle,
two of the most connective nodes are MAP kinase 1
(MAPK1; cluster 1) and P4. MAPK1 acts as an interconnec-
tion for many cellular processes and is involved in the
regulation of translation and gene activation (Rolli-
Derkinderen et al. 2003). In contrast to the ‘oestrus
interaction network’, much more nuclear factors can be
found at dioestrus correlating with the diverse functional
classes of genes found as up-regulated at dioestrus.
The process angiogenesis is connected in both the
interaction networks with a number of genes that
predominantly have been described as positive regulators
of this process. Some of them are more related to
angiogenesis in the context of tumour progression and
invasion, such as PLAT (tissue plasminogen activator;
cluster 1), TIMP2, MMP2 and MET (hepatocyte growth
factor receptor; cluster 2; Fridman et al. 1992, Diaz et al.
2002, Ma et al. 2003). Genes with higher mRNA levels
during the luteal phase, which are more directly involved
in angiogenesis are ephrin-A1 (EFNA1), endothelial
differentiation sphingolipid G-protein-coupled receptor,
3 (EDG3), angiotensinogen (AGT), endothelial PASwww.reproduction-online.orgdomain protein 1 (EPAS1; hypoxia-inducible factor 2-a)
and Kruppel-like factor 5 (KLF5; clusters 1, 1, 2, 1, 2). AGT
codes for the progenitor of angiotensin II, which has been
described to function as a vasoconstrictor and to regulate
fetoplacental angiogenesis in the ovine placenta (Zheng
et al. 2005). EPAS1 and KLF5 code for transcription factors
controlling the expression of vascular endothelial growth
factor (VEGF ), VEGF receptor 1 (FLT1), VEGF receptor 2
(KDR), and TEK (Takeda et al. 2004) and of platelet-derived
growth factor (PDGF ), early growth response 1, (EGR1),
plasminogen activator inhibitor type 1 (SERPINE1),
inducible nitric oxide synthase 2A (NOS2A), and VEGF
receptor genes (Nagai et al. 2005), respectively. KLF5 is
down-regulated with vascular development (Nagai et al.
2005), which is in line with the KLF5 mRNA expression
profile observed in the bovine endometrium during the
oestrous cycle (increased mRNA levels at days 3.5, 12,
18P4H; cluster 2) and its target TEK (highest mRNA levels
at days 18P4L and 0; cluster 5).
In addition to PLAT, MET, TIMP2 and MMP2, the gene
products of cystatin M (CST6; cluster 1), teratocarci-
noma-derived growth factor 1 (TDGF1; cluster 1),
integrin-b4 (ITGB4; cluster 2) and DnaJ-like heat shock
protein 40 (DNAJB4; cluster 2) are connected with the
process invasive growth and are thus potentially involved
in the regulation of embryo implantation. Some of these
genes were described as negative regulators of invasive
growth, e.g. PLAT (Lin et al. 2001) and CST6 (Shridhar
et al. 2004). Expression of integrins in the context of
embryo implantation has been investigated in the human
and mouse endometrium and in domestic animals (Aplin
1997, Burghardt et al. 2002).
A number of genes with higher mRNA levels during
the luteal phase are related to the process of cell
adhesion. However, only one of these genes –
LGALS3BP, coding for galectin-3-binding protein, also
known as Mac-2-binding protein (cluster 2) – is a
candidate for cell–cell adhesion (Inohara et al. 1996).
In one of our previous studies, LGALS3BP mRNA
concentration was higher in day 18 pregnant endome-
trium versus day 18 control endometrium and mRNA
expression localised to the luminal epithelium
(Bauersachs et al. 2006).
During the pre-implantation phase, feeding of the
elongating embryo is an important function of theReproduction (2008) 135 225–240
236 K Mitko and othersendometrium. This phase corresponds to the luteal phase
of the oestrous cycle. In this context, a number of genes
related to several metabolic functions were up-regulated
during the luteal phase, such as mitochondrial aconitase
2 (ACO2), oxoglutarate dehydrogenase (OGDH), iso-
citrate dehydrogenase 1 (IDH1) and IDH2 (clusters 1, 2,
1, 1), which are involved in the TCA cycle. Furthermore,
genes encoding different transporters were identified as
up-regulated during the luteal phase. SLC1A1 (cluster 1)
codes for a glutamate transporter that has been detected
in the human placenta and suggested to be involved in
the active transport of glutamate between the fetal and
maternal blood circulation (Noorlander et al. 2004).
SLC11A2 (cluster 2) encodes a metal ion transporter
expressed in the human placenta (Chong et al. 2005).
SLC16A1 (cluster 2) codes for monocarboxylate trans-
porter 8, described as a powerful and specific thyroid
hormone (TH) membrane transporter with an important
role in the TH transport during fetal development and a
specific role in the human placental development (Chan
et al. 2006). Selenoprotein P (SEPP1; cluster 1) is a
selenium supply protein (Saito & Takahashi 2002) and
ectonucleotide pyrophosphatase/phosphodiesterase 1
(ENPP1; cluster 2) regulates extracellular pyrophosphate
concentrations (Hessle et al. 2002).
The probable functions of the six genes, which were
selected for mRNA in situ hybridisation, are discussed in
the following in detail. These genes were selected based
on their potential role for the regulation of the
preparation of the endometrium for embryo implan-
tation. In cattle, implantation is non-invasive (placenta
epitheliochorealis). The luminal epithelium of the
endometrium remains mainly intact except for the
formation of giant cells, which are the fusion products
of the epithelial and trophoblast cells (Wathes &
Wooding 1980). The exchange of nutrients takes place
by diffusion through the epithelium, providing an
appropriate environment for the developing embryo.
Tight junction barriers of the luminal epithelium regulate
the passage of ions, water and molecules through the
paracellular space (Gonzalez- Mariscal et al. 2003) and
separate the very different maternal and embryonic
milieu (Hees & Sinowatz 1992). Three mRNAs coding
for tight junction proteins show differential expression
during the oestrous cycle: CLDN10, CLDN4 and TJP1
(zona occludens 1). Claudins, for example, are tight
junction-associated adhesion molecules involved in the
formation of epithelial barriers and are directly involved
in intercellular sealing in the simple epithelia (Tsukita &
Furuse 2002). The mRNA coding for CLDN10 is strongly
up-regulated at oestrus (cluster 5), whereas the mRNA
level of CLDN4 is increased at dioestrus with the highest
levels during the late luteal phase (cluster 1). TJP1 mRNA
expression showed the lowest levels at day 0, increased
until day 12 and decreased thereafter (cluster 2). Both the
claudin mRNAs are mainly localised in the luminal
epithelium and the superficial glands. In situReproduction (2008) 135 225–240hybridisation for TJP1 mRNA showed in addition strong
staining of the deeper endometrial glands. In mice, Tjp1
has been shown to take part in the formation of a
temporary barrier in the cells of the primary decidual
zone that restricts the passage of injurious stimuli such as
maternal immunoglobulins to the embryo (Wang et al.
2004). The differential regulation of mRNAs coding for
tight junction proteins suggests an important role
regarding the preparation of the endometrium for
embryo implantation and protection of the embryo
from the maternal immune system.
The proprotein convertase subtilisin/kexin type 5
(PCSK5), also known as prohormone convertase 5 or
protease PC6, has been shown to convert inactive
precursors to their mature active forms (Seidah &
Chretien 1999). One of the proteins that first occur as
immature precursors and become activated by PCSK5 is
VEGF (Popovici et al. 2000), which is known to be
involved in the regulation of angiogenesis (Carmeliet
2005; see above). Strong induction of PCSK5 protein has
been shown in uterine stromal cells specifically at the
site of embryo attachment during early pregnancy in
mice and during the phase of uterine receptivity and at
implantation in primates. In vivo blocking of uterine
production of PCSK5 protein in mice resulted in total
inhibition of implantation (Nie et al. 2003, 2005). In
contrast, in our present study, the mRNA expression of
PCSK5 was the highest at oestrus and decreased during
the luteal phase (cluster 3). PCSK5 may be an example
for species-specific differences of gene expression
regulation due to its essential role in the regulation of
invasive type of implantation. Furthermore, in situ
hybridisation revealed a stronger staining in the luminal
epithelial cells and the superficial glands than in the
stromal cells. The higher mRNA levels observed during
oestrus may be associated with angiogenesis and
remodelling of the ECM , since PCSK5 has been shown
to play a central role in the MT-MMP-MMP-2 proteolytic
cascade (Stawowy et al. 2005).
MAGED1 mRNA was up-regulated at oestrus (day 0)
and down-regulated at dioestrus (cluster 5) and mainly
localised in the superficial uterine glands and the
luminal epithelium. While the melanoma antigen family
genes, MAGEA and MAGEB, are silent in the normal
tissues with the exception of testis and placenta, the
MAGED genes are expressed ubiquitously. MAGED1,
also known as NRAGE, has been shown to alter the
cytoskeleton, to inhibit cell–cell adhesion and to
suppress mRNA expression and activity of MMP2 (Chu
et al. 2007). Another member of this gene family,
MAGED2, was found as up-regulated during dioestrus
(cluster 1), suggesting that genes of this family may also
play a role in cellular adhesion processes.
LGALS1 mRNA concentration was increased at oestrus
(cluster 5). In situ hybridisation revealed pronounced
staining in the superficial epithelial glands and weak-
to-moderate staining in other cells. The LGALS1 protein, awww.reproduction-online.org
Expression profiling of bovine endometrium 237multifunctional secreted member of the galectin family,
plays a pivotal role in the modulation of cell adhesion, cell
growth, inflammation and angiogenesis (Almkvist &
Karlsson 2004, von Wolff et al. 2005, Thijssen et al.
2006). In the human endometrium, LGALS1 protein has
been mainly localised in the stromal cells with increased
expression in the late secretory phase and in the decidual
tissue (von Wolff et al. 2005). The contrary spatial and
temporal expression of LGALS1 in the bovine and human
endometrium, i.e. between species with different types of
placentation, suggests this gene as a further interesting
candidate for the regulation of embryo implantation.
In conclusion, the present study revealed distinct
dynamic expression profiles and identified numerous
genes differentially expressed in the bovine endometrium
during the oestrous cycle. The function of many of these
genes, especially with respect to the preparation of the
endometrium for implantation, is still unknown. The
results of this study provide the basis for an in-depth
analysis of individual genes/proteins or particularly
interesting components of regulatory networks in the
bovine uterus during the oestrous cycle and early
pregnancy. From a practical perspective, knowledge of
physiological changes in the endometrial transcriptome
profiles during the oestrous cycle is important for the
development of array-based diagnostic procedures to
assess aberrant gene expression profiles associated with
reduced maternal fertility or metabolic problems of high
yielding dairy cows.Materials and Methods
Pretreatment of animals and collection of endometrial
tissue samples
Cyclic heifers (Bos taurus, Simmental Fleckvieh) between 17 and
31 months old were synchronised by an i.m. injection of a single
dose of 500 mg cloprostenol (Estrumate; Essex Tierarznei,
Munich, Germany) at dioestrus. Around 60 h after Estrumate
injection, standing heat was identified through observation of
sexual behaviour (i.e. toleration, sweating, vaginal mucus). In
addition, ultrasound-guided follicle monitoring was performed.
Blood samples were taken 2 days before oestrus (day 0), at oestrus
and just before slaughtering todetermine serum P4 levels (Prakash
et al. 1987). For the determination of serum LH levels bya specific
RIA (Schams & Karg 1969), blood samples were taken in intervals
of 6 hours for the day 0 group. Animals were slaughtered on days
0 (oestrus, within 12 hrs after the LH surge; nZ4), 3.5 (nZ4), 12
(dioestrus, luteal phase; nZ4) and 18 of the oestrus cycle (nZ8;
4 with high and 4 with low serum P4 levels) respectively. After
slaughter, the uterus was removed, dissected from the surround-
ing tissue, opened longitudinally and divided into seven sections:
corpus plus caudal, middle and cranial parts of the ipsilateral and
the contralateral uterine horns (Bauersachs et al. 2005). For the
analyses in the present study, tissue samples of the middle part of
the ipsilateral horn were used. Samples (about 250 mg) were
carefully cut from the intercaruncular endometrium with a
scalpel within 20 min after slaughter of the donor animal andwww.reproduction-online.orgimmediately transferred into vials containing 4 ml RNAlater
(Ambion, Huntingdon, Cambridgeshire, UK) and incubated
overnight at 4 8C. The samples were stored at K20 8C until
further processing. Tissue samples for in situ hybridisation were
collected from the sameanimals and the same location within the
uterus and fixed by immersion in formalin (3.7%) and then
routinely processed for embedding in paraffin. All experiments
with animals were conducted with permission from the local
veterinary authorities and in accord with the accepted standards
of humane animal care.Preparation of cDNA arrays and cDNA array
hybridisation
The generation of the BOE array has been described previously
(Bauersachs et al. 2007). Fifteen microlitres of the PCR products of
the cDNA fragments and 15 ml long oligonucleotides (50 ng/ml;
Operon, Cologne, Germany) were transferred to 384-well
microtitre plates (Abgene, Epsom, Surrey, UK) containing 15 ml
twofold spotting buffer (40 mM Tris–HCl (pH 8.0), 2 M NaCl,
2 mM EDTA, bromophenol blue). A total of 1344 cDNA fragments
and 96 oligonucleotides were spotted onto nylon membranes
(Nytran Plus; Whatman Schleicher & Schuell, Dassel, Germany)
on an area of 20!50 mm using a microarray robot (Omnigrid
Accent; Gene Machines, Ann Arbor, MI, USA) and solid pins
(SSP015, diameter 0.015 inch; Telechem International, Sunny-
vale, CA, USA). Spotting was done six times for each PCR product
on the same position for sufficient and equal application. Thirty-
two arrays were produced simultaneously. The spotted DNA was
denatured by incubation with 0.5 M NaOH for 20 min at room
temperature. Subsequently, DNA was immobilised by baking for
30 min at 80 8C and u.v. crosslinking (120 mJ/cm2; XL-1500 u.v.
crosslinker; Spectronics Corp., Westbury, NY, USA). Total RNA
was isolated from 20 endometrial tissue samples using TRIzol
(Invitrogen), according to the manufacturer’s instructions. The
quantity and quality of total RNA were determined by spec-
trometry and agarose gel electrophoresis respectively. Double-
stranded (ds) cDNAwas synthesised starting with 50 mg total RNA
using Superscript III (200 U/ml, Invitrogen) and 50 pmol cDNA
synthesis primer (GAGAT20VN; VZA, C or G) for first-strand
synthesis. The second strand was synthesised with Escherichia coli
DNA polymerase I (40 U), E. coli RNase H (2 U) and E. coli DNA
ligase (10 U; Invitrogen), according to the manufacturer’s
instructions. Ribosomal and other residual RNAs were digested
with 5 ml RNase (0.5 mg/ml, DNase free, from bovine pancreas;
Roche Diagnostics) for 90 min at 37 8C. Remaining nucleotides
and primers were removed using Microspin S200-HR spin
columns (GE Healthcare Life Science, Munich, Germany).
Subsequently, cDNA was precipitated with 15 ml of 3 M NaOAc
and 150 ml isopropanol. Dry sediment was solubilised in 20 ml of
0.5! Tris/HCl–EDTA (TE) buffer (pH 8.0). The quality of cDNA
was determined by agarose gel electrophoresis.
33P-labelled cDNA probes (four for each group) were generated
from ds cDNA corresponding to 7.5–15 mg total RNA. CDNAwas
heat denatured for 10 min at 96 8C and then chilled on ice. High
prime reaction mixture (Roche), dNTP mixture (dCTP final
concentration 10 pmol/ml, dATP, dGTP and dTTP final concen-
tration each 100 pmol/ml) and 90 mCi a-33PdCTP were added to a
final volume of 20 ml. Reaction mixtures were incubated for 1 h atReproduction (2008) 135 225–240
238 K Mitko and others37 8C, heat inactivated for 20 min at 65 8C and purified with
ProbeQuant G50 spin columns (GE Healthcare Life Science) to
remove unincorporated nucleotides and to estimate labelling
efficiency. Hybridisation was done as follows: pre-hybridisation
was done for five arrays together in one 15 cm glass hybridisation
bottle: 2!10 min 10 ml 0.1! PBS/1% SDS at 85 8C; 3!10 min
10 ml 1! PBS/10% SDS at 65 8C and 1!10 min 10 ml
1! PBS/10% SDS at room temperature. Hybridisation probes
were denatured for 15 min at 96 8C immediately before adding
them to the hybridisation solution. Hybridisation was done in
plastic vials (Poly-Q vials, 18 ml; Beckman Coulter, Munich,
Germany) in 2.5 ml 1! PBS (pH 7.5)/10% SDS for 47 h at 65 8C.
After hybridisation, the arrays were put together in 15 cm glass
hybridisation bottles, five arrays per bottle, and washed as follows:
3!5 min 10 ml 1! PBS/10% SDS at 65 8C; 3!10 min 10 ml
1! PBS/10% SDS at 65 8C; 3!10 min 10 ml 0.1! PBS/1% SDS
at 65 8C and 3!5 min 10 ml 1! PBS/1% SDS/2 mM EDTA at
30 8C. Filters were dried by baking at 80 8C for 20 min. The filters
were exposed to an imaging plate BAS-SR (Fuji Photo Film Co.,
purchased from Raytest, Straubenhardt,Germany). Imagingplates
were scanned with a phosphor imager (Typhoon Imager; GE
Healthcare Life Science). Labelling and hybridisation were done
in parallel for all the 20 samples.Analysis of array data
The data discussed in this publication have been deposited in
NCBI’s Gene Expression Omnibus (GEO, http://www.ncbi.nlm.
nih.gov/geo/) and are accessible through GEO Series accession
number GSE8337. Array evaluation was done using AIDA Image
Analyzer software (version 3.52; Raytest). Background was
subtracted with the ‘lowest grid dot’ function. Raw data were
normalised with the BioConductor package vsn (Huber et al.
2002). For quality control, normalised data were analysed with a
distance matrix and a heatmap based on pair-wise distances
(BioConducter package geneplotter). Significance analysis was
performed using the ‘significance analysis of microarrays’
method (SAM, Multiclass; Tusher et al. 2001). Data from
cDNAs with significant changes during the oestrous cycle was
used for cluster analyses with MultiExperiment Viewer 4.0 (Saeed
et al. 2003). For hierarchical clustering of genes and samples,
HCL support trees were used based on mean centred values (log2
value of a gene minus mean of all 19 log2 values of this gene). For
SOTA (cluster analysis for identification of similar expression
profiles), means for each of the five groups were calculated and
mean centred (mean log2 value group minus mean of all the five
groups). Quantitatively enriched GO categories were identified
using GOTM (Zhang et al. 2004) and OntoExpress (Draghici et al.
2003). Integrated analysis of different functional databases was
done using the ‘functional annotation clustering’ tool of the
DAVID (Dennis et al. 2003). Genes were assigned to KEGG
pathways (http://www.genome.ad.jp/kegg/tool/search_pathway.
html) based on the Entrez Gene ID of the putative human
orthologous gene. Interaction networks were built using Pathway
Architect software (version 2.0.1; Stratagene). Most of the
interactions and cellular localisations provided by the Pathway
Architect databases were checked. Additional interactions found
in the literature were assigned to the network.Reproduction (2008) 135 225–240Quantitative real-time RT-PCR
Real-time RT-PCR was performed as described previously
(Ulbrich et al. 2004). The following primers (PCR product
length in parentheses) were used to amplify specific fragments
referring to selected mRNAs: CLDN10 (forward: 5 0-CATTT-
CATGCCAATCAGGG, reverse: 5 0-CGCTGGACGGTTACATCC
(97 bp)), IRF1 (forward: 5 0-TCTGCTTAATGAACCTGGGG,
reverse: 5 0-TATCAGGCCAATATAACCCCC (103 bp)), LGALS1
(forward: 5 0-AGTGTCGTGGAGGTATGCATC, reverse:
5 0-TGAAGTCACCACCTGCAGAC (133 bp)), PCKS5 (forward:
5 0-ATGTCAAACAGCTGGCGTC, reverse: 5 0-TACTTCATG-
GAGGAGCGGAG (115 bp)), PLA2 G10 (forward: 5 0-TT-
GTGTGGGAACTACTCACCC, reverse: 5 0-TCAAACTGGAAA-
CCAAACTGG (211 bp)), PFN1 (forward: 5 0-CCCCAACCTT-
CAATATCACG, reverse: 5 0-TTTCTTGTTGATCATACCGCC
(95 bp)), SERPING1 (forward: 5 0-AAATGACAGCACAGCCAGC,
reverse: 5 0-CTATCTTCCACTTGGCGCTC (149 bp)), STC1
(forward: 5 0-CATATTCGTCCATGGCCAG, reverse: 5 0-GGT-
TGCCCCAGTAGAGTTAGC (124 bp)), TDGF1 (forward:
5 0-TCATGCAGATTTCATGACCTG, reverse: 5 0-TTTAGGGAC-
CACAGGGAAATC (110 bp)), TNC (forward: 5 0-ACT- TTAGCT-
CCTGCCAGAYG, reverse: 5 0-TAAGTTTCCGGGGACAACTG
(124 bp)), TJP1 (forward: 5 0-GCTCTAAAATCATCCGACTCCTC,
reverse: 5 0-ACAGAAACACAGTTTGCTC- CAAC (104 bp)) and
18S rRNA (forward: 5 0-AAGTCTTTGGGTTCCGGG, reverse: 5 0-
GGACATCTAAGGGCATCACA (365 bp)). All amplified PCR
fragments were sequenced to verify the resulting PCR product
(MWG-Biotech, Ebersberg, Germany). The annealing tempera-
ture (AT) and the appropriate fluorescence acquisition (FA)
points for quantification within the fourth step of the
amplification segment were as follows: 18S rRNA (AT 60 8C,
FA 82 8C); IRF1, LGALS1, PLA2G10, TNC, PFN1 (AT 60 8C, FA
80 8C); CLDN10 (AT 64 8C, FA 80 8C); PCKS5 (AT 66 8C, FA
74 8C); SERPING1 (AT 64 8C, FA 85 8C); STC1 (AT 66 8C, FA
74 8C); TDGF1 (AT 60 8C, FA 74 8C) and TJP1 (AT 64 8C, FA
77 8C). The cycle number required to achieve a definite SYBR
Green fluorescence signal (CP) was calculated by the second
derivative maximum method (LightCycler software version
4.05; Roche Diagnostics). The CP is correlated inversely with
the logarithm of the initial template concentration. The CP
determined for the target genes were normalised against 18S
rRNA (DCP). Differences between the groups of the different
cycle stages are expressed by theDDCPas well as the mean fold
changes in relation to the cycle stage having the lowest
expression (Livak & Schmittgen 2001). The differences between
the groups were analysed using one-way ANOVA. The normal
distribution was tested by the Kolmogorov–Smirnov method,
followed by a Holm–Sidak test to find the significant differences
(Sigma-Stat, version 2.03). The overall level of significance (P
value) is shown in Table 1.In situ hybridisation
In situ hybridisation of 5 mm paraffin sections of the
endometrium samples was performed as described previously
(Bauersachs et al. 2005). The sequences of the antisense
oligonucleotides were as follows: CLDN10, 5 0-ATGGGCAG-
GAGCCTCACTCT; CLDN4, 5 0-AACATCGTCACGTCGCAGAC;www.reproduction-online.org
Expression profiling of bovine endometrium 239LGALS1, 5 0-TGTGCCTCCACTTCAACCCT; MAGED1, 5 0-GT-
CATCTTCATGAATGGCAAC; PCSK5, 5 0-GCAGAGCTGT-
AGTATCAGCTA; TJP1, 5 0-AGAGGCCTCACATGAAGCCA.
Negative controls were done by omitting the oligonucleotide
probe and by hybridisation with sense oligonucleotide probes
(complementary sequence of the antisense oligonucleotides).Declaration of interest
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6 Perspectives 
Based on the results of this work it can be concluded that the BOE array is applicable for the 
analysis of mRNA expression profiles in bovine endometrial samples. There are manifold 
applications for the BOE array in basic and applied research for the analysis of normal and 
pathological physiology associated with endometrial transcriptome changes. One interesting 
field for the use of the BOE array are the influences of assisted reproduction techniques 
(ART) on endometrial transcriptome profiles. ART become increasingly important in human 
reproductive medicine and in animal breeding and biotechnology as well. Although in vitro 
fertilisation and intracytoplasmic sperm injection have been established to the level of clinical 
application, there are recent reports of a higher frequency of epigenetic abnormalities in 
offspring derived from ART as compared to natural reproduction (Horsthemke and Ludwig 
2005). Somatic cell nuclear transfer cloning, which has been successful in a number of 
species, is particularly critical with respect to epigenetic abnormalities of the resulting 
embryos, foetuses and offspring (reviewed in (Shi, Zakhartchenko et al. 2003)). However, it 
is largely unclear whether and how epigenetic abnormalities cause developmental 
abnormalities and abortions of cloned embryos or foetuses. A number of studies revealed 
placental abnormalities as primary cause of pregnancy loss after transfer of bovine SCNT 
embryos. Placental changes include a reduced number, but increased size of placentomes 
(Chavatte-Palmer, Heyman et al. 2002; Constant, Guillomot et al. 2006). Therefore, it would 
be interesting to study, how and when these changes of placental functionality are induced, 
which could be examined by evaluating transcriptome profiles of endometrium samples in 
response to SCNT embryos vs. embryos derived by in vitro fertilisation.  
Furthermore, future applications of the BOE array could be systematic studies of 
interrelations between the metabolic status of dairy cows and the functionality of the 
endometrium to identify differentially expressed genes or characteristic expression profiles of 
sets of genes that could be used for differential diagnosis of fertility problems. Currently it is 
discussed, whether the decrease in reproductive performance of high performance milk cows 
(Butler 1998) is directly due to the high milk yield, negative energy balance and associated 
metabolic problems (“the physiological hypothesis”) or if there has been an unintended 
selection for gene variants with a negative effect on fertility during the efficient selection for 
high milk yield (“the genetic hypothesis”). In theory, beneath malfunctions of the ovaries, 
problems related to uterus physiology (e.g. disturbed uterine receptivity leading to early 
embryonic mortality) may be responsible for the overall alarming fertility problems in high 
yielding dairy cows. It has been shown that stimulation of milk production by increased intake 
of dietary protein leads to an increase in blood urea nitrogen (Ishikawa, Kaisho et al.) 
(Ishikawa, Kaisho et al.) and is often associated with decreased fertility (Butler 1998). Early 
studies of dairy cows involving embryo collection and evaluation did not provide evidence 
that high dietary protein has an impact on ovarian follicular development, ovulation, or 
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fertilisation of oocytes (Blanchard, Ferguson et al. 1990; Garcia-Bojalil, Staples et al. 1994). 
Thus, disturbances of early embryonic development and embryo-maternal interactions are 
more likely an explanation for fertility problems associated with high yield and protein 
feeding. Although it is not clear whether the embryonic or the maternal compartment is more 
critical, there is evidence that high protein diet and the associated increase in BUN may 
change the uterine milieu, e.g. the uterine pH, which may have important implications for the 
transcriptional activity and functions of the endometrium. Interestingly, bovine endometrial 
cells in culture are known to respond directly to increasing urea concentrations with 
increased secretion of PGF2α (Butler 1998) which induces luteolysis in vivo (Wolf, Arnold et 
al. 2003). Moreover, there is evidence for embryotoxic effects of PGF2α in the pre-
implantation period (Buford, Ahmad et al. 1996) . These observations provide a plausible link 
between elevated plasma urea nitrogen concentrations and decreased fertility. However, the 
molecular mechanisms underlying the effects of increased BUN or other metabolic changes 
on endometrial functions are incompletely understood and need to be studied in vivo. The 
use of transcriptome profiling of endometrial biopsies from metabolically well-characterised 
cows in different situations of milk yield and energy balance could help to further characterise 
these interrelations. Such studies could clarify metabolic influences on the functionality of the 
endometrium and eventually make an important contribution to the fertility monitoring in high-
yielding cows.  
In addition to these questions related to basic research, endometrial transcriptome profiles 
may have important applications for the cattle breeding industry. Future studies will clarify 
whether transcriptome profiles of endometrium biopsies taken at a specific stage of the 
oestrous cycle are indicative of the fertility status. If this turns out to be the case, detailed 
molecular phenotyping could be combined with genotyping using a high-density marker set. 
Thus associations between a favourable endometrial transcriptome profile and specific 
genetic markers, could be established, eventually realising the concept of genomic selection 
(Meuwissen, Hayes et al. 2001) for fertility.  
For the further development of the BOE array establishing a non-radioactive microarray 
technology in addition to our approved technique, which is based on radioactive labelleing, 
would be important to permit robust serial analyses. The first step could be for instance to 
establish a microarray technology based on long oligonucleotides as probes and detection 
via fluorescence labelling. This technical improvement would permit the analysis of large sets 
of samples at moderate costs and the automation of hybridisation and washing of 
microarrays, which is not possible with radioactivity-based techniques. 
Future RNA expression studies should also take non-coding RNAs and microRNAs, 
important regulators of translation, into account. In addition to profiling at the RNA level 
proteomics studies of endometrium and of the uterine fluid will be essential to identify 
biologically relevant protein candidates. Novel proteomics techniques, such as highly 
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sensitive saturation labelling (Kondo and Hirohashi 2006), will further increase the analytical 
depth of proteome studies and facilitate analyses of microdissected tissues. 
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7 Summary 
Dynamic transcriptome profiling of bovine endometrium during the oestrous cycle 
Fertility problems are the main reason for slaughter of high-performance milk cows, because 
prolonged calving intervals result in financial losses for the farmer and retard genetic 
progress. Genetic improvement of fertility would be of great benefit, but functional traits for 
effective selection are missing. Recent advances in functional genomics tools like DNA 
microarrays could be the key to identify gene expression patterns in the endometrium that 
correlate with maternal fertility. Therefore, a bovine oviduct and endometrium cDNA array 
was established that contains a set of 1,440 cDNA clones and long oligonucleotides 
representing 950 different genes. The major part of these genes results from a series of 
differential gene expression studies in endometrium (different stages of the oestrous cycle, 
day 18 and day 15 pregnant vs. nonpregnant) and oviduct epithelial cells (different stages of 
the oestrous cycle). 
Using this custom-made cDNA array the response of the endometrium was studied to the 
changing hormonal environment during the bovine oestrous cycle. Endometrium samples 
were recovered from Simmental heifers slaughtered on day 0 (oestrus), 3.5 (metoestrus), 12 
(dioestrus) and 18. The latter group was divided into animals with high (late dioestrus) and 
low progesterone levels (preoestrus). Statistical analysis with the Significance Analysis of 
Microarrays (SAM) method revealed 269 genes exhibiting significant changes in their 
transcript levels during the oestrous cycle in distinct temporal patterns. Two major types of 
expression profiles were observed, which showed the highest mRNA levels during the 
oestrus phase or the highest levels during the luteal phase, respectively. A minor group of 
genes exhibited the highest mRNA levels on day 3.5. Gene ontology (GO) analyses revealed 
GO categories related to extracellular matrix remodelling, transport, and cell growth and 
morphogenesis enriched at oestrus, whereas immune response and particular metabolic 
pathways were overrepresented at dioestrus. 
Generation of gene interaction networks uncovered genes possibly involved in biological 
processes important for establishment of early pregnancy, such as endometrial remodelling 
(e.g. collagen genes, MMP2, TIMP1), regulation of angiogenesis (e.g. ANGPTL2, TEK), 
regulation of invasive growth (e.g. PCSK5, tight junction proteins, ITGB4), cell adhesion (e.g. 
MUC16, LGALS3BP) and embryo feeding (e.g. SLC1A1, ENPP1). Localisation of mRNA 
expression in the endometrium was analysed for CLDN4, CLDN10, TJP1, PCSK5, MAGED1, 
and LGALS1.  
Future application of the BOE array, based on the knowledge from the cycle study, could be 
the use in systematic studies of interactions between the metabolic status and functionality of 
the endometrium to identify genes that could be used for differential diagnosis of fertility 
problems. 
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8 Zusammenfassung 
Dynamische Transkriptionsprofile während des Sexualzyklus im Endometrium beim 
Rind 
Fruchtbarkeitsprobleme sind die Hauptursache für die Schlachtung von Hochleistungs-
Milchkühen, da verlängerte Zwischenkalbezeiten finanzielle Verluste für den Tierhalter und 
eine Verzögerung des Züchtungsfortschrittes bedeuten. Eine positive züchterische 
Beeinflussung der Fruchtbarkeit wäre von großem Vorteil, ist aber derzeit nicht möglich, da 
Funktionsparameter für eine effektive Selektion fehlen. Die neuesten Fortschritte im Bereich 
der funktionalen Genomanalyse, wie z.B. DNA-Microarrays könnten der Schlüssel zur 
Identifizierung von Genexpressionsmustern im Endometrium, die mit der maternalen Fertilität 
korrelieren, sein. Daher wurde ein bovines Ovidukt- und Endometrium-cDNA-Array 
entwickelt, welches ein Set von 1.400 cDNA-Klonen und langen Oligonukleotiden enthält, die 
950 unterschiedliche Gene repräsentieren. Der Großteil dieser Gene stammt aus einer Folge 
von verschiedenen Genexpressionsstudien im Endometrium (verschiedene Zyklusstadien, 
Tag 18 und Tag 15 trächtig vs. nichtträchtige Tiere) und in Eileiterepithelzellen (verschiedene 
Stadien des Sexualzyklus). 
Mit Hilfe dieses selbst hergestellten cDNA-Arrays wurde die Reaktion des Endometriums auf 
die sich verändernden Hormonspiegel während des bovinen Sexualzyklus auf der Ebene der 
mRNA untersucht. Endometriumproben wurden von Färsen der Rasse Simmentaler 
Fleckvieh gewonnen, die am Zyklustag 0 (Östrus), 3,5 (Metöstrus), 12 (Diöstrus) und 18 
geschlachtet wurden. Die letzte Gruppe wurde unterteilt in Tiere mit hohem (später Diöstrus) 
oder niedrigen Blutprogesteronwerten (Proöstrus) zum Schlachtzeitpunkt. Statistische 
Analysen mit der SAM-Methode (Significance Analysis of Microarrays) ergaben 269 Gene, 
deren mRNA-Konzentrationen sich während des Zyklus in ausgeprägten zeitlichen Mustern 
veränderten. Zwei Haupttypen von Expressionsmustern wurden beobachtet, die ihre 
höchsten mRNA-Spiegel entweder während des Östrus oder der Lutealphase haben. Eine 
kleinere Gruppe von Genen zeigte die höchsten mRNA-Spiegel an Tag 3,5. Gene Ontology 
(GO) Analysen ergaben während des Östrus angereicherte GO-Kategorien, die mit dem 
Umbau der extrazellulären Matrix, Transportprozessen, Zellwachstum und –umwandlung in 
Zusammenhang stehen, während im Diöstrus Kategorien wie Immunantwort und bestimmte 
Stoffwechsel-Pathways überrepräsentiert waren. 
Mit Hilfe der Erstellung von Interaktionsnetzwerken wurden Gene identifiziert, die in 
biologische Prozesse involviert sind, welche für die Aufrechterhaltung der frühen Trächtigkeit 
wichtig sein könnten. Zu diesen Prozessen gehören der Umbau des Endometriums (z.B. 
Kollagene, MMP2, TIMP1), die Regulierung der Angiogenese (z.B. ANGPTL2, TEK), die 
Regulierung von invasiven Wachstumspozessen (z.B. PCSK5, Tight junction Proteine, 
ITGB4) und die Ernährung des Embryos (z.B. SLC1A1, ENPP1). Zur weiteren 
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Charakterisierung ausgewählter Gene wurde die Lokalisation der mRNA Expression im 
Endometrium für CLDN4, CLDN10, TJP1, PCSK5, MAGED1 und LGALS1 untersucht. 
 Basierend auf den Ergebnissen der dynamischen Expressionsstudie während des Zyklus 
könnten ein zukünftiges Anwendungsgebiet des BOE-Arrays systematischen Studien von 
Interaktionen zwischen dem metabolischen Status und der Funktionalität des Endometriums 
sein, um Gene zu finden, die zur Differentialdiagnostik bei Fruchtbarkeitsproblemen genutzt 
werden können. 
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10 Appendix 
 
 
Supplemental Figure 1: 
Hierarchical clustering of genes and samples. Mean centred values (log2 value of a gene 
minus mean of all 19 log2 values of this gene) of cDNAs with significant changes during the 
oestrous cycle were used for HCL support trees (MultiExperiment Viewer 4.0). Colour coding 
of the support trees: black: 100% support; grey: 90-100%, blue: 80-90%, green: 70-80%, 
yellow: 60-70%, orange: 50-60%, pink: 0-50%, red: 0% support (percentage of time a given 
node was supported over the resampling trials). 
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Supplemental Table 1: 
All significant revealing differentially expressed genes, ordered according to cluster affiliation 
 
Gene description of best BLAST hit Gene name Gene symbol Acc. no. BLAST hit Relative expression Score 
(d) 
q-
value 
(%) 
Local 
FDR 
Clu
ster 
    
Acc. no. 
BOE EST 
Entrez 
Gene ID 
bta 
Entrez 
Gene 
ID hsa 
Day 
18P4
L 
Day 0 Day 
3.5 
Day 
12 
Day 
18P4H 
    
Bos taurus isolate 32027 
mitochondrion, complete genome 
16SrRNA 16SrRNA AY676873    1.3 1.0 1.3 2.5 2.4 0.37 1.02 7.46 1 
Bos taurus aconitase 2, 
mitochondrial (ACO2) 
aconitase 2, mitochondrial ACO2 NM_173977 EB086479 280976 50 1.1 1.0 1.0 2.1 2.8 0.50 0.00 0.00 1 
Bos taurus acetyl-Coenzyme A 
synthetase 2 (AMP forming)-like 
(ACAS2L) 
acyl-CoA synthetase short-chain 
family member 1 
ACSS1 NM_174746 EB086816 282873 84532 2.5 1.0 2.1 17.1 8.4 1.20 0.00 0.00 1 
Bos taurus aldose reductase 
(AKR1B1) 
aldo-keto reductase family 1, 
member B1 (aldose reductase) 
AKR1B1 NM_001012519  317748 231 1.5 1.0 1.1 5.2 1.8 0.61 0.00 0.00 1 
Bos taurus Rho GDP dissociation 
inhibitor (GDI) beta (ARHGDIB) 
Rho GDP dissociation inhibitor (GDI) 
beta 
ARHGDIB NM_175797  327676 397 1.7 1.0 1.9 5.0 5.1 0.63 0.03 0.02 1 
Homo sapiens ATPase, Na+/K+ 
transporting, beta 2 polypeptide 
(cDNA clone IMAGE:5733940), with 
apparent retained intron 
ATPase, Na+/K+ transporting, beta 2 
polypeptide 
ATP1B2 BC035801 DV549142 282562 482 1.4 1.0 1.4 8.4 2.2 0.90 0.00 0.00 1 
Homo sapiens ATP synthase, H+ 
transporting, mitochondrial F0 
complex, subunit C3 (subunit 9) 
(ATP5G3), nuclear gene encoding 
mitochondrial protein, transcript 
variant 2 
ATP synthase, H+ transporting, 
mitochondrial F0 complex, subunit 
C3 (subunit 9) 
ATP5G3 NM_001689  540176 518 1.3 1.0 1.1 1.8 2.0 0.38 0.77 6.04 1 
PREDICTED: Bos taurus similar to 
branched chain aminotransferase 1, 
cytosolic, transcript variant 1 
(LOC505926) 
branched chain aminotransferase 1, 
cytosolic 
BCAT1 XM_582290  505926 586 1.8 1.0 1.1 6.1 2.9 0.61 0.00 0.00 1 
PREDICTED: Bos taurus similar to 
Chromosome 14 open reading 
frame 73 (LOC615559) 
chromosome 14 open reading frame 
73 
C17orf73 XM_687402 DV549110 615559 91828 1.3 1.0 1.0 3.0 2.0 0.43 0.24 1.17 1 
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PREDICTED: Bos taurus similar to 
Complement C4 precursor 
(LOC617689) 
complement component 4A C4A XM_869995  280678 720 1.8 1.0 1.6 2.9 3.5 0.54 0.15 1.25 1 
Bos taurus transcription factor 
RAM2 (CDCA7L) 
cell division cycle 7 homolog CDCA7L NM_001104977 DV549229 514631 55536 1.1 1.0 1.1 2.2 1.9 0.61 1.02 8.32 1 
PREDICTED: Bos taurus similar to 
cytoskeleton-associated protein 4 
(LOC515784) 
cytoskeleton-associated protein 4 CKAP4 XM_868540 EB086377 515784 10970 1.9 1.7 1.0 6.4 2.8 0.82 0.00 0.05 1 
PREDICTED: Bos taurus similar to 
Chloride channel protein ClC-Kb 
(Chloride channel Kb) (ClC-K2) 
(LOC538145) 
chloride channel Kb CLCKNB XM_618340  538145 1188 1.2 1.0 1.0 5.8 1.7 0.92 0.00 0.05 1 
Bos taurus claudin-4 (CLDN4) claudin-4 CLDN4 NM_001014391  414921 1364 1.7 1.2 1.0 2.8 3.3 0.51 0.00 0.00 1 
PREDICTED: Bos taurus similar to 
CCR4-NOT transcription complex, 
subunit 1 isoform a (LOC533968) 
CCR4-NOT transcription complex, 
subunit 1 
CNOT1 XM_613555 DV549140 533968 23019 1.0 1.0 1.2 2.6 1.3 0.45 0.18 0.16 1 
Bos taurus cystatin E/M (CST6) cystatin E/M CST6 NM_001012764  503685 1474 1.0 1.0 1.0 6.3 2.3 0.69 0.00 0.00 1 
Bos taurus chemokine (C-X-C motif) 
receptor 4 (CXCR4) 
chemokine (C-X-C motif) receptor 4 CXCR4 NM_174301 EB086565 281736 7852 1.0 1.1 1.3 2.0 2.2 0.36 1.02 8.52 1 
PREDICTED: Bos taurus similar to 
Cytochrome P450 26A1 (Retinoic 
acid-metabolizing cytochrome) 
(P450RAI) (Retinoic acid 4-
hydroxylase), transcript variant 1 
(LOC539047) 
cytochrome P450, family 26, 
subfamily A, polypeptide 1 
CYP26A1 XM_584484  539047 1592 1.4 1.0 1.1 33.3 25.2 1.14 0.00 0.00 1 
Homo sapiens cytochrome P450, 
family 39, subfamily A, polypeptide 
1 (CYP39A1) 
cytochrome P450, family 39, 
subfamily A, polypeptide 1 
CYP39A1 NM_016593  511195 51302 1.1 1.0 1.2 8.3 5.0 0.92 0.00 0.00 1 
Bos taurus putative diacylglycerol 
O-acyltransferase (DGAT2) 
diacylglycerol O-acyltransferase 
homolog 2 (mouse) 
DGAT2 NM_205793  404192 84649 1.0 1.2 1.2 17.1 1.8 1.02 0.00 0.01 1 
PREDICTED: Bos taurus similar to 
deltex 3-like (LOC515051) 
deltex 3-like (Drosophila) DTX3L XM_592997 DV936239 515051 151636 1.4 1.0 1.4 2.6 2.2 0.57 0.77 6.15 1 
Contig57350, Chr.15, 
ENSBTAG00000004046 
deltex 4 homolog (Drosophila) DTX4 ENSBTAG00000004046 EB086367  23220 1.8 1.4 1.0 4.3 1.3 0.54 0.00 0.00 1 
PREDICTED: Bos taurus similar to 
endothelial differentiation 
sphingolipid G-protein-coupled 
receptor 3, transcript variant 1 
(LOC539123) 
endothelial differentiation, 
sphingolipid G-protein-coupled 
receptor, 3 
EDG3 XM_001252512 DV936182 539123 1903 1.1 1.0 1.2 2.4 1.9 0.46 0.10 0.00 1 
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Bos taurus similar to ephrin A1 
isoform a precursor (MGC128366) 
ephrin-A1 EFNA1 NM_001034292 DV549172 507319 1942 1.6 1.0 1.1 2.9 2.7 0.48 0.10 0.00 1 
CR382918 Bovine multi-stage 
muscles library (bcaj) Bos taurus 
cDNA clone bcaj0005a.c.05 5prim 
sequence 
endothelial PAS domain protein 1 EPAS1 CR382918 EB086495 282711 2034 1.6 1.4 1.0 2.1 2.8 0.39 0.61 4.36 1 
PREDICTED: Bos taurus similar to 
expressed sequence AV312086, 
transcript variant 1 (LOC537453) 
hypothetical protein FLJ36874 FLJ36874 XM_872692 EB086580 537453 219988 1.3 1.0 1.4 2.8 2.3 0.45 0.18 0.26 1 
PREDICTED: Bos taurus similar to 
FXYD domain containing ion 
transport regulator 4, transcript 
variant 3 (LOC506918) 
FXYD domain containing ion 
transport regulator 4 
FXYD4 XM_583436  506918 53823 2.4 2.1 1.0 38.0 10.9 1.76 0.00 0.00 1 
Bos taurus growth arrest and DNA-
damage-inducible, gamma 
(GADD45G) 
growth arrest and DNA-damage-
inducible, gamma 
GADD45G NM_001045901 EB086401 504939 10912 1.6 1.2 1.0 4.8 3.1 0.87 0.00 0.06 1 
PREDICTED: Bos taurus similar to 
UDP-GalNAc:polypeptide N-
acetylgalactosaminyl transferase 
(LOC616218) 
UDP-N-acetyl-alpha-D-
galactosamine:polypeptide N-
acetylgalactosaminyltransferase 2 
(GalNAc-T2) 
GALNT2 XM_868188  616268 2590 1.0 1.0 1.0 2.6 2.3 0.47 0.10 0.00 1 
PREDICTED: Bos taurus similar to 
GM2 ganglioside activator protein 
(LOC504524) 
GM2 ganglioside activator GM2A XM_580665 DV549156 504524 2760 1.1 1.0 1.7 9.2 3.2 0.90 0.00 0.05 1 
Homo sapiens helicase with zinc 
finger domain (HELZ) 
helicase with zinc finger HELZ NM_014877 DV549164  9931 1.4 1.1 1.0 3.1 2.6 0.67 0.00 0.00 1 
Bos taurus isocitrate 
dehydrogenase 1 (NADP+), soluble 
(IDH1) 
isocitrate dehydrogenase 1 
(NADP+), soluble 
IDH1 NM_181012 DV936319 281235 3417 1.2 1.6 1.0 5.3 3.9 0.76 0.00 0.00 1 
Bos taurus isocitrate 
dehydrogenase 2 (NADP+), 
mitochondrial (IDH2) 
isocitrate dehydrogenase 2 
(NADP+), mitochondrial 
IDH2 NM_175790 DV549177 327669 3418 1.4 1.0 1.4 4.7 2.0 0.68 0.00 0.00 1 
PREDICTED: Bos taurus 
hypothetical LOC506759, transcript 
variant 2 (LOC506759); 
Contig61327, ChrUn.478 
interferon, gamma-inducible protein 
16 
IFI16 XM_863928 DV936501 506759 3428 1.2 1.0 1.0 1.9 2.3 0.41 0.43 3.16 1 
Bos taurus similar to putative 
ISG12(a) protein (ISG12(A)) 
interferon, alpha-inducible protein 27 IFI27 NM_001038050 DV936232 507138 3429 1.4 1.2 1.0 2.2 2.2 0.40 0.43 3.79 1 
PREDICTED: Bos taurus similar to 
melanoma differentiation associated 
protein-5 (LOC535490) 
interferon induced with helicase C 
domain 1 
IFIH1 XM_615590 EB086701 535490 64135 2.0 1.2 1.0 6.2 2.0 0.69 0.00 0.00 1 
Bos taurus similar to Interferon interferon regulatory factor 6 IRF6 NM_001076934  614253 3664 1.6 1.0 1.3 5.3 4.5 0.83 0.00 0.06 1 
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regulatory factor 6 (IRF-6), 
(MGC143192) 
Bos taurus interferon-stimulated 
protein, 15 kDa (ISG15) 
ISG15 ubiquitin-like modifier ISG15 NM_174366 DV936411 281871 9636 1.3 1.0 1.1 2.8 1.9 0.44 0.32 1.84 1 
1183530 MARC 7BOV Bos taurus 
cDNA 5' sequence; 
SCAFFOLD110056 
kinase suppressor of ras 2 KSR2  DV549180  283455 1.2 1.3 1.0 2.5 2.3 0.42 0.34 1.90 1 
Bos taurus legumain (LGMN) legumain LGMN NM_174101 EB086855 281281 5641 1.2 1.0 1.3 3.6 2.4 0.47 0.12 0.45 1 
UMC-bend_0B01-024-d11 Day 16 
Uterus from a pregnant animal bend 
Bos taurus cDNA 3' sequence 
lipase A, lysosomal acid, cholesterol 
esterase (Wolman disease) 
LIPA CO728274 DV936145  3988 2.3 1.4 1.0 6.3 2.3 0.71 0.00 0.00 1 
PREDICTED: Bos taurus similar to 
LMBR1L protein (LOC539015) 
limb region 1 homolog (mouse)-like LMBR1L XR_027670  539015 55716 1.0 1.0 1.2 1.8 1.8 0.41 0.43 3.13 1 
PREDICTED: Homo sapiens similar 
to WDNM1-like protein 
(LOC650626) 
similar to WDNM1 homolog LOC650626 XM_939715 EB086745  650626 1.2 1.0 1.0 6.7 9.0 0.73 0.00 0.00 1 
Contig38875, ChrUn.41 hypothetical protein LOC784115 LOC784115  DV936147 784115  3.1 1.0 1.0 9.3 23.0 0.86 0.00 0.06 1 
PREDICTED: Bos taurus 
hypothetical protein LOC787439 
(LOC787439) 
hypothetical protein LOC787439 LOC787439 XM_001254835 DV936226 787439  1.6 1.3 1.0 1.5 2.2 0.36 1.02 8.41 1 
Mus musculus low density 
lipoprotein receptor-related protein 2 
(cDNA clone IMAGE:4974943), 
partial cds 
low density lipoprotein receptor-
related protein 2 
LRP2 BC040788 DV549139  4036 1.0 1.3 1.0 6.1 2.4 0.53 0.00 0.00 1 
PREDICTED: Bos taurus similar to 
Lymphocyte antigen 6 complex 
locus G6C protein precursor 
(LOC505805) 
lymphocyte antigen 6 complex, locus 
G6C 
LY6G6C NM_001077856  505805 80740 1.9 1.0 1.3 55.9 15.6 1.29 0.00 0.00 1 
PREDICTED: Bos taurus similar to 
lymphocyte antigen 6 complex, 
locus G6E, transcript variant 1 
(LOC512743) 
lymphocyte antigen 6 complex, locus 
G6E 
LY6G6E NM_024123 DV549163 512743 79136 1.2 1.0 1.2 10.9 3.8 0.48 0.10 0.00 1 
Bos taurus similar to Melanoma-
associated antigen D2 (MAGE-D2 
antigen) (MAGE-D) (Breast cancer 
associated gene 1 protein) (BCG-1) 
(11B6) (Hepatocellular carcinoma 
associated protein JCL-1) 
(MGC139951) 
melanoma antigen family D, 2 MAGED2 NM_001075665  514372 10916 1.0 1.0 1.2 1.4 2.1 0.45 0.18 0.08 1 
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000929BEMN030540HT BEMN Bos 
taurus cDNA sequence; Homo 
sapiens mitogen-activated protein 
kinase 1 (MAPK1), transcript  
variant 1 
mitogen-activated protein kinase 1 MAPK1 DY168238  327672 5594 1.0 1.0 1.2 3.2 6.8 1.03 0.00 0.01 1 
PREDICTED: Bos taurus similar to 
N-benzoyl-L-tyrosyl-p-amino-
benzoic acid hydrolase beta subunit, 
transcript variant 1 (LOC540701) 
meprin A, beta MEP1B XM_612703  540701 4225 1.5 1.0 2.2 12.2 14.7 0.75 0.00 0.00 1 
Bos taurus membrane spanning 4-
domain subfamily A member 8B 
(ms4A8B) 
ms4A8B protein MS4A8B NM_001034056  415111 83661 1.8 1.2 1.0 5.2 5.1 0.62 0.00 0.00 1 
Bos taurus interferon-inducible 
myxovirus resistance-1 protein  
(Mx1) gene, Mx1-a allele, exon 15 
and complete cds 
myxovirus (influenza) resistance 1, 
(murine homolog) 
MX1 AY251202  280872 4599 1.3 1.0 1.2 2.3 2.0 0.38 0.82 6.77 1 
Bos taurus similar to N-myc 
downstream regulated gene 4 
(MGC140660) 
NDRG family member 4 NDRG4 NM_001075695 DV549184 515033 65009 1.2 1.4 1.0 4.7 1.8 0.64 0.00 0.00 1 
968490 MARC 4BOV Bos taurus 
cDNA 3' 
nebulette NEBL CK846036 DV549174  10529 1.2 1.1 1.0 4.5 2.2 0.71 0.00 0.00 1 
PREDICTED: Bos taurus similar to 
Sialidase 1 precursor (Lysosomal 
sialidase) (N-acetyl-alpha-
neuraminidase 1) (Acetylneuraminyl 
hydrolase) (G9 sialidase) 
(LOC505554) 
sialidase 1 (lysosomal sialidase) NEU1 XM_581856  505554 4758 1.4 1.4 1.0 1.7 2.3 0.38 0.77 6.81 1 
Bos taurus Niemann-Pick disease, 
type C1 (NPC1) 
Niemann-Pick disease, type C1 NPC1 NM_174758  286772 4864 1.3 1.0 1.2 2.3 2.0 0.50 0.00 0.00 1 
Bos taurus 2',5'-oligoadenylate 
synthetase 1, 40/46kDa (OAS1) 
2',5'-oligoadenylate synthetase 1, 
40/46kDa 
OAS1 NM_001040606 DV936307 654488 4938 1.1 1.0 1.1 2.4 1.9 0.40 0.43 3.77 1 
Bos taurus similar to 
phosphatidylethanolamine-binding 
protein 4 (MGC127772) 
phosphatidylethanolamine-binding 
protein 4 
PEBP4 NM_001034440  513254 157310 1.6 1.0 1.1 4.0 2.1 0.54 0.02 0.00 1 
Bos taurus proenkephalin (PENK) proenkephalin PENK NM_174141 DV936200 281387 5179 1.5 1.0 1.2 24.8 45.1 1.51 0.00 0.01 1 
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PREDICTED: Bos taurus similar to 
Group 10 secretory phospholipase 
A2 precursor (Group X secretory 
phospholipase A2) 
(Phosphatidylcholine 2-
acylhydrolase GX) (GX sPLA2) 
(sPLA2-X), transcript variant 1 
(LOC613966) 
phospholipase A2, group X PLA2G10 XM_864950 DV549157 613966 8399 2.4 1.0 2.1 8.1 3.9 0.73 0.00 0.00 1 
Tissue plasminogen activator plasminogen activator, tissue PLAT X85800  281407 5327 1.9 1.2 1.0 2.1 2.0 0.37 1.02 7.78 1 
Bos taurus retinoic acid receptor 
responder (tazarotene induced) 2 
(RARRES2) 
retinoic acid receptor responder 
(tazarotene induced) 2 
RARRES2 NM_001046020 DV549112 508990 5919 1.4 1.1 1.0 5.1 5.8 1.01 0.00 0.01 1 
Bos taurus receptor accessory 
protein 6 (REEP6) 
receptor accessory protein 6 REEP6 NM_001046605 DV936150 617543 92840 1.3 1.0 1.1 2.7 1.7 0.37 0.77 7.17 1 
PREDICTED: Bos taurus similar to 
RalBP1 associated Eps domain 
containing protein 1 (RalBP1-
interacting protein 1), transcript 
variant 1 (LOC536155) 
RALBP1 associated Eps domain 
containing 1 
REPS1 XM_616276  536155 85021 1.4 1.0 1.5 3.0 2.2 0.48 0.34 2.65 1 
BP111960 ORCS bovine utero-
placenta cDNA Bos taurus cDNA 
clone ORCS12550 5' 
ribosomal protein L36a RPL36A BP111960  508165 6173 1.7 2.1 1.0 3.9 1.5 0.39 0.61 4.42 1 
Bos taurus reticulon 3 (RTN3) reticulon 3 RTN3 NM_182657  359721 10313 1.0 1.1 1.0 2.2 1.5 0.38 0.77 6.69 1 
Bos taurus selenoprotein P-like 
protein precursor (SEPP1) 
selenoprotein P-like protein 
precursor 
SEPP1 NM_174459 DV549257 282066 6414 1.2 1.0 1.4 3.5 3.5 0.69 0.00 0.03 1 
Bos taurus serine (or cysteine) 
proteinase inhibitor, clade G (C1 
inhibitor), member 1, (angioedema, 
hereditary) (SERPING1) 
serine (or cysteine) proteinase 
inhibitor, clade G (C1 inhibitor), 
member 1, (angioedema, hereditary) 
SERPING1 NM_174821 EB086646 281035 710 1.9 1.0 1.9 5.8 4.0 0.72 0.00 0.01 1 
Homo sapiens SH3 multiple 
domains 1 (SH3MD1) 
SH3 and PX domains 2A SH3PXD2A NM_014631   9644 1.6 1.0 1.7 3.3 3.9 0.75 0.00 0.00 1 
LB0024.CR_A11 GC_BGC-02 Bos 
taurus cDNA clone IMAGE:7898005 
5' sequence 
solute carrier family 1 
(neuronal/epithelial high affinity 
glutamate transporter, system Xag), 
member 1 
SLC1A1 DN825839   6505 1.7 1.0 1.4 3.6 4.1 0.44 0.24 0.45 1 
Bos taurus SWI/SNF related, matrix 
associated, actin dependent 
regulator of chromatin, subfamily b, 
member 1 (SMARCB1) 
SWI/SNF related, matrix associated, 
actin dependent regulator of 
chromatin, subfamily b, member 1 
SMARCB1 NM_001040557 DV549104 537412 6598 1.2 1.3 1.0 5.9 9.1 1.09 0.00 0.00 1 
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Bos taurus teratocarcinoma-derived 
growth factor 1 (TDGF1) 
teratocarcinoma-derived growth 
factor 1 
TDGF1 NM_001080358 DV549151 784029 6997 1.1 1.0 1.0 28.0 1.4 1.10 0.00 0.00 1 
PREDICTED: Bos taurus similar to 
LOC443715 protein, transcript 
variant 1 (LOC615277) 
thioesterase superfamily member 4 THEM4 XM_589824 DV936288 615277 117145 1.8 1.6 1.0 2.1 5.4 0.44 0.24 0.55 1 
PREDICTED: Bos taurus similar to 
LOC443715 protein, transcript 
variant 1 (LOC615277) 
thioesterase superfamily member 5 THEM5 XM_589824  615277 284486 6.3 1.0 1.0 14.9 43.0 0.76 0.14 1.15 1 
Bos taurus tissue inhibitor of 
mettaloproteinase 2 (TIMP2) 
tissue inhibitor of mettaloproteinase 
2 
TIMP2 NM_174472  282093 7077 1.8 1.4 1.0 8.9 2.8 0.92 0.00 0.02 1 
PREDICTED: Bos taurus similar to 
oxidized-LDL responsive gene 2, 
transcript variant 2 (LOC509642) 
tubulointerstitial nephritis antigen-like 
1 
TINAGL1 XM_882308  509642 64129 2.3 1.0 1.0 2.5 3.2 0.36 1.02 9.38 1 
Ovis aries UDP-
glucuronosyltransferase 
(SHEUGT1A07) 
UDP glucuronosyltransferase 1 
family, polypeptide A6 
UGT1A6 NM_001009189   54578 1.9 1.0 1.5 5.1 3.4 0.55 0.00 0.00 1 
Reptig1015998, ChrUn.10273 unknown unknown     1.3 1.0 1.6 9.1 13.0 0.90 0.00 0.05 1 
PREDICTED: Bos taurus similar to 
KIAA1404 protein (LOC539807) 
zinc finger, NFX1-type containing 1 ZNFX1 XM_589621 EB086754 539807 57169 2.2 1.0 1.3 8.5 3.4 0.70 0.09 0.16 1 
4082241 BARC 9BOV Bos taurus 
cDNA clone 9BOV20_L10 3' 
ATP-binding cassette, sub-family G 
(WHITE), member 1 
ABCG1 CK966960 DV549193  9619 1.2 1.0 1.9 4.4 1.7 0.54 0.00 0.00 2 
PREDICTED: Bos taurus similar to 
Y55F3AM.10 (LOC615289) 
abhydrolase domain containing 14B ABHD14B XM_867054 DV549126 615289 84836 1.1 1.0 2.0 3.0 1.5 0.60 0.00 0.00 2 
PREDICTED: Bos taurus similar to 
ankyrin repeat and  BTB (POZ) 
domain containing 1 (LOC507417) 
ankyrin repeat and BTB (POZ) 
domain containing 1 
ABTB1 XM_584015 DV549205 507417 80325 1.2 1.0 2.7 3.3 3.8 0.64 0.00 0.00 2 
757911 MARC 6BOV Bos taurus 
cDNA 3' sequence 
angiotensinogen (serine (or 
cysteine) proteinase inhibitor, clade 
A (alpha-1 antiproteinase, 
antitrypsin), member 8) 
AGT CB533310 DV549136 527114 183 1.5 1.0 3.4 14.5 6.6 0.91 0.00 0.05 2 
Bos taurus alkaline phosphatase, 
liver/bone/kidney (ALPL) 
alkaline phosphatase, 
liver/bone/kidney 
ALPL NM_176858  280994 249 1.8 1.0 2.5 6.7 3.2 0.64 0.05 0.02 2 
Bos taurus annexin A8 (ANXA8) annexin A8 ANXA8 NM_174241  281627 244 1.2 1.0 2.1 2.6 1.7 0.41 0.48 2.97 2 
Bos taurus beta-2-microglobulin 
(B2M) 
beta-2-microglobulin B2M NM_173893  280729 567 1.7 1.0 1.7 2.2 1.5 0.38 0.77 6.15 2 
Bos taurus BAI1-associated protein 
2-like 2 (BAIAP2L2) 
BAI1-associated protein 2-like 2 BAIAP2L2 NM_001035498  617924 80115 1.2 1.0 2.8 8.9 4.8 0.89 0.00 0.00 2 
Chr.19 50940107-50940208; Bos 
taurus similar to CG8841-PA, 
isoform A (MGC139628) 
chromosome 17 open reading frame 
28 
C17orf28 NM_001076924  540436 283987 1.3 1.0 1.5 2.8 1.7 0.50 0.00 0.00 2 
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Bos taurus complement component 
1, r subcomponent (C1R) 
complement component 1, r 
subcomponent 
C1R NM_001034407  511581 715 1.9 1.0 2.5 2.8 3.8 0.45 0.31 2.10 2 
Homo sapiens mRNA; cDNA 
DKFZp761M0111 (from clone 
DKFZp761M0111) 
chromosome 6 open reading frame 
155 
C6orf155 AL137346 DV549169  79940 1.0 1.1 2.0 2.8 1.7 0.50 0.00 0.00 2 
PREDICTED: Bos taurus similar to 
Calpain 5, transcript variant 1 
(LOC536988) 
calpain 5 CAPN5 XM_617141  536988 726 1.0 1.0 1.6 1.8 1.4 0.38 0.77 6.36 2 
Bos taurus cyclin B1 (CCNB1) cyclin B1 CCNB1 NM_001045872 DV549111 327679 891 1.0 1.4 2.7 4.7 1.3 0.52 0.15 1.05 2 
Bos taurus cyclin D3 (CCND3) cyclin D3 CCND3 NM_001034709  540547 896 2.0 1.0 4.2 8.8 5.4 0.71 0.00 0.00 2 
Bos taurus similar to CD74 antigen 
isoform b (MGC127643) 
CD74 antigen (invariant polypeptide 
of major histocompatibility complex, 
class II antigen-associated) 
CD74 NM_001034735 EB086792 281059 972 1.9 1.0 3.4 2.5 2.3 0.51 0.00 0.00 2 
Bos taurus CD81 antigen (target of 
antiproliferative antibody 1) (CD81) 
CD81 molecule CD81 NM_001035099  511435 975 1.0 1.3 2.1 2.1 1.4 0.42 0.79 4.88 2 
PREDICTED: Bos taurus 
hypothetical LOC516405, transcript 
variant 1 (LOC516405) 
carboxymethylenebutenolidase 
homolog (Pseudomonas) 
CMBL XM_594558 DV549147 516405 134147 1.0 1.1 1.5 2.5 1.5 0.45 0.18 0.16 2 
Mus musculus cyclin M3 (Cnnm3), 
transcript variant 2 
cyclin M3 CNNM3 NM_053186 EB086820  26505 1.0 1.0 1.8 2.1 2.1 0.50 0.00 0.00 2 
Homo sapiens collagen, type V, 
alpha 3 (COL5A3) 
collagen, type V, alpha 3 COL5A3 NM_015719   50509 1.0 1.5 2.0 3.1 1.5 0.53 0.00 0.00 2 
PREDICTED: Bos taurus similar to 
cryptochrome 2 (photolyase-like) 
(LOC509058) 
cryptochrome 2 (photolyase-like) CRY2 XM_585942 EB086714 509058 1408 1.4 1.0 2.5 4.6 2.6 0.78 0.00 0.02 2 
PREDICTED: Bos taurus similar to 
Cytochrome P450 27, mitochondrial 
precursor (Cytochrome P-
450C27/25) (Sterol 26-hydroxylase) 
(Sterol 27-hydroxylase) (Vitamin 
D(3) 25-hydroxylase) (5-beta-
cholestane-3-alpha,7-alpha,12-
alpha-triol 27-hydroxylase), 
transcript variant 1 (LOC511960) 
cytochrome P450, family 27, 
subfamily A, polypeptide 1 
CYP27A1 XM_589389  511960 1593 1.0 1.0 2.0 5.7 3.1 0.87 0.00 0.06 2 
Chr.16 27117065-27117459; nr-, 
est-, repetetiv, locus for similar to 
flavin containing monooxygenase 4 
(H.s.) 
DnaJ (Hsp40) homolog, subfamily B, 
member 4 
DNAJB4 NM_007034   11080 1.0 1.3 2.0 2.6 2.6 0.49 0.10 0.00 2 
Homo sapiens eukaryotic translation 
elongation factor 1 alpha 1 
(EEF1A1) 
eukaryotic translation elongation 
factor 1 alpha 1 
EEF1A1 NM_001402  282220 1915 1.1 1.0 1.5 2.1 2.3 0.40 0.61 3.89 2 
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PREDICTED: Bos taurus similar to 
ectonucleotide 
pyrophosphatase/phosphodiesteras
e 1 (LOC615535), partial mRNA 
ectonucleotide 
pyrophosphatase/phosphodiesterase 
1 
ENPP1 XM_867376  615535 5167 1.1 1.0 2.3 4.6 2.8 0.62 0.00 0.00 2 
Bos taurus similar to epoxide 
hydrolase 1 (MGC126963) 
epoxide hydrolase 1, microsomal 
(xenobiotic) 
EPHX1 NM_001034629  535293 2052 1.0 1.3 2.1 2.8 1.5 0.45 0.18 0.02 2 
Bos taurus similar to epoxide 
hydrolase 2, cytoplasmic 
(MGC139743) 
epoxide hydrolase 2, cytoplasmic EPHX2 NM_001075534  511716 2053 1.0 1.1 2.0 5.0 2.2 0.69 0.00 0.03 2 
BP162142 full-length enriched 
swine cDNA library, adult thymus 
Sus scrofa cDNA clone 
THY010001C04 5' sequence; 
SCAFFOLD215209 
family with sequence similarity 53, 
member B 
FAM53B BP162142 EB086632  9679 1.3 1.0 1.9 2.3 3.1 0.44 0.24 0.47 2 
4103922 BARC 9BOV Bos taurus 
cDNA clone 9BOV26_C17 5' 
sequencePREDICTED: Bos taurus 
similar to expressed sequence 
AV312086, transcript variant 1 
(LOC537453) Contig50573, Chr.16 
flavin containing monooxygenase 4 FMO4 CK973468  537453 2329 1.1 1.0 3.2 7.7 5.6 0.70 0.00 0.00 2 
1459642 MARC 7BOV Bos taurus 
cDNA 5' sequence; Contig70678, 
Chr.5, ENSBTAG00000000015 
FAD-dependent oxidoreductase 
domain containing 2 
FOXRED2 DT897387   80020 2.8 2.4 4.1 6.7 1.0 0.62 0.00 0.00 2 
Bos taurus GABA(A) receptor-
associated protein like 1 
(GABARAPL1) 
GABA(A) receptor-associated 
protein like 1 
GABARAPL1 NM_001033616 EB086780 338472 23710 1.7 1.0 1.9 2.5 2.3 0.40 0.61 4.25 2 
Homo sapiens chromosome 7 
genomic contig, reference 
assembly; Contig3104, Chr.4, 
ENSBTAG00000020228 
HECT, C2 and WW domain 
containing E3 ubiquitin protein ligase 
1 
HECW1 NT_007819  514243 23072 1.2 1.0 2.2 3.2 3.3 0.47 0.10 0.00 2 
Homo sapiens cDNA clone 
MGC:134704 IMAGE:40022212, 
complete cds 
HFM1, ATP-dependent DNA 
helicase homolog (S. cerevisiae) 
HFM1 BC114377   164045 2.0 1.0 2.5 3.5 3.0 0.37 0.77 6.85 2 
Bos taurus isolate 23_24+_+F05.1 
MHC class I antigen (Duffy, Crowe 
et al.) gene, partial cds 
major histocompatibility complex, 
class I, C 
HLA-C DQ121198  515712 3107 1.8 1.0 2.0 3.1 2.1 0.41 0.44 3.22 2 
PREDICTED: Bos taurus similar to 
heterogeneous nuclear 
ribonucleoprotein L isoform a, 
transcript variant 4 (LOC504520) 
heterogeneous nuclear 
ribonucleoprotein L 
HNRPL XM_580661  504520 3191 1.8 1.0 1.8 2.7 2.5 0.39 0.61 4.53 2 
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Bos taurus similar to putative 6-16 
protein (6-16) 
interferon, alpha-inducible protein 6 IFI6 NM_001075588 DV936154 512913 2537 1.3 1.0 2.1 3.6 1.6 0.48 0.27 2.00 2 
interferon responsive factor 1 interferon responsive factor 1 IRF1 NM_177432  337917 3659 1.5 1.0 2.0 2.5 3.4 0.48 0.10 0.00 2 
Bos taurus interferon-stimulated 
transcription factor 3, gamma 48kDa 
(ISGF3G) 
interferon-stimulated transcription 
factor 3, gamma 48kDa 
ISFG3G NM_001024506  509855 10379 1.1 1.0 1.4 2.0 1.7 0.39 0.61 4.86 2 
PREDICTED: Bos taurus similar to 
integrin beta 4 isoform 3 precursor, 
transcript variant 1 (LOC506995) 
integrin, beta 4 ITGB4 XM_583533 DV549165 506995 3691 1.1 1.0 1.5 3.3 2.2 0.57 0.00 0.00 2 
Bos taurus integral membrane 
protein 2B (ITM2B) 
integral membrane protein 2B ITM2B NM_001035093  510575 9445 1.0 1.1 1.7 1.6 1.6 0.42 0.30 2.00 2 
PREDICTED: Bos taurus similar to 
colon Kruppel-like factor, transcript 
variant 3 (LOC535702) 
Kruppel-like factor 5 (intestinal) KLF5 XM_866267  535702 688 1.0 1.0 2.0 2.6 2.4 0.48 0.10 0.00 2 
PREDICTED: Bos taurus similar to 
KIAA0342 protein (LOC509859) 
lupus brain antigen 1 LBA1 XR_028825 DV936435 509859 9881 1.0 1.3 2.3 1.9 1.6 0.48 0.10 0.00 2 
Bos taurus similar to Galectin-3 
binding protein precursor (Lectin 
galactoside-binding soluble 3 
binding protein) (Mac-2 binding 
protein) (Mac-2 BP) (MAC2BP) 
(Tumor-associated antigen 90K) 
(MGC127786) 
lectin, galactoside-binding, soluble, 3 
binding protein 
LGALS3BP NM_001046316 EB086737 531137 3959 1.7 1.0 2.2 3.7 2.6 0.41 0.43 3.03 2 
Bos taurus likely ortholog of mouse 
D11lgp2 (LGP2) 
likely ortholog of mouse D11lgp2 LGP2 NM_001015545  508378 79132 1.5 1.0 2.1 3.4 2.7 0.58 0.00 0.00 2 
Bos taurus similar to Lymphocyte 
antigen Ly-6E precursor (Retinoic 
acid-induced gene E protein) (RIG-
E) (Thymic shared antigen 1) (TSA-
1) (Stem cell antigen 2) (SCA-2) 
(MGC140297) 
lymphocyte antigen 6 complex, locus 
E 
LY6E NM_001046070 DV549155 510977 4061 1.2 1.0 1.5 4.1 1.8 0.58 0.00 0.00 2 
Bos taurus methionine 
adenosyltransferase II, beta 
(MAT2B) 
methionine adenosyltransferase II, 
beta 
MAT2B NM_001046526  614177 27430 1.0 1.2 1.7 1.9 1.7 0.38 0.77 5.91 2 
Bos taurus clone RP42-135P2, 
complete sequence 
met proto-oncogene (hepatocyte 
growth factor receptor) 
MET AC087860 EB086573 280855 4233 1.0 1.1 1.4 1.6 2.4 0.38 0.77 6.36 2 
Bos taurus matrix Gla protein 
mRNA, complete cds 
matrix Gla protein MGP AF210379  282660 4256 1.6 1.0 3.8 4.7 5.2 0.74 0.00 0.00 2 
Bos taurus isolate 15_16+_+A06.1 
MHC class I antigen (Duffy, Crowe 
et al.) gene, partial cds 
MHC Class I antigen MHC1 DQ121168    1.3 1.0 2.0 2.7 2.0 0.41 0.43 3.05 2 
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Bos taurus matrix metalloproteinase 
2 (72 KDa type IV collagenase) 
(MMP2) 
matrix metalloproteinase 2 
(gelatinase A, 72kDa gelatinase, 
72kDa type IV collagenase) 
MMP2 NM_174745 DV549221 282872 4313 1.4 1.2 3.5 1.4 1.0 0.39 0.61 5.37 2 
Contig36704, ChrUn.74, 
ENSBTAG00000000991 
mitochondrial ribosomal protein L32 MRPL32    64983 1.8 1.0 2.5 3.2 5.6 0.64 0.00 0.00 2 
Bos taurus mitochondrial ribosomal 
protein S36 (MRPS36) 
mitochondrial ribosomal protein S36 MRPS36 NM_001035438  613835 92259 1.5 1.3 2.2 6.2 1.0 0.67 0.00 0.00 2 
Homo sapiens myotubularin related 
protein 3 (MTMR3), transcript 
variant 1 
myotubularin related protein 3 MTMR3 NM_153050 DV549128 281924 8897 2.0 1.0 3.7 18.5 9.6 1.45 0.00 0.00 2 
Bos taurus neuronatin (cDNA clone 
MGC:128097 IMAGE:7989543), 
complete cds 
neuronatin NNAT BC103128  353114 4826 1.0 1.5 4.0 2.7 1.3 0.45 0.18 0.02 2 
PREDICTED: Bos taurus similar to 
Nuclear protein 1 (Protein p8) 
(Candidate of metastasis 1), 
transcript variant 1 (MGC128797) 
nuclear protein 1; p8 protein 
(candidate of metastasis 1) 
NUPR1 XM_867457 DV936172 614673 26471 1.0 2.2 2.9 4.0 2.5 0.51 0.05 0.00 2 
Bos taurus similar to oxoglutarate 
(alpha-ketoglutarate) 
dehydrogenase (lipoamide) isoform 
1 precursor (MGC137985) 
oxoglutarate (alpha-ketoglutarate) 
dehydrogenase (lipoamide) 
OGDH NM_001076030  534599 4967 2.0 1.0 2.6 11.3 3.1 0.68 0.00 0.00 2 
PREDICTED: Bos taurus similar to 
Poly [ADP-ribose] polymerase 10 
(PARP-10) (LOC510991) 
poly (ADP-ribose) polymerase 
family, member 10 
PARP10 CK837739 EB086718 510991 84875 1.0 1.0 2.2 2.6 2.1 0.55 0.00 0.00 2 
771635 MARC 6BOV Bos taurus 
cDNA 3' sequence 
poly (ADP-ribose) polymerase 
family, member 12 
PARP12 CB536605 EB086691 513185 64761 1.2 1.0 1.8 2.2 1.7 0.40 0.66 4.57 2 
Bos taurus similar to poly(rC) 
binding protein 2 (MGC127996) 
poly(rC) binding protein 2 PCBP2 NM_001034711  540653 5094 1.1 1.0 2.1 1.6 1.1 0.45 0.18 0.07 2 
4100874 BARC 10BOV Bos taurus 
cDNA clone 10BOV7_D17 5' 
PCI domain containing 2 PCID2 CK960198 DV549118 617943 55795 1.0 1.1 2.4 2.7 2.1 0.52 0.00 0.00 2 
Bos taurus anti-oxidant protein 2 
(non-selenium glutathione 
peroxidase, acidic calcium-
independent phospholipase A2) 
(AOP2) 
peroxiredoxin 6 PRDX6 NM_174643  282438 9588 1.2 1.0 1.7 2.5 1.4 0.44 0.24 0.54 2 
Bos taurus proteasome (prosome, 
macropain) inhibitor subunit 1 (PI31) 
(PSMF1) 
proteasome (prosome, macropain) 
inhibitor subunit 1 (PI31) 
PSMF1 NM_001076478 EB086753 617807 9491 1.5 1.0 2.1 2.7 2.3 0.46 0.10 0.00 2 
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Bos taurus similar to Diamine 
acetyltransferase 1 
(Spermidine/spermine N(1)-
acetyltransferase 1) (SSAT) (SSAT-
1) (Putrescine acetyltransferase) 
(Polyamine N-acetyltransferase 1) 
(MGC127572) 
spermidine/spermine N1-
acetyltransferase 1 
SAT1 NM_001034333  508861 6303 1.2 1.0 1.5 3.0 1.4 0.44 0.39 3.03 2 
Homo sapiens clone DNA176108 
scavenger receptor hlg (UNQ2938) 
mRNA, complete cds 
scavenger receptor class A, member 
5 (putative) 
SCARA5 DV549113   286133 1.2 1.0 7.1 17.9 18.2 1.29 0.00 0.00 2 
Bos taurus similar to solute carrier 
family 11 (proton-coupled divalent 
metal ion transporters), member 2 
(MGC138014) 
solute carrier family 11 (proton-
coupled divalent metal ion 
transporters), member 2 
SLC11A2 NM_001046121  512464 4891 2.3 1.0 2.4 7.7 4.8 0.70 0.00 0.01 2 
PREDICTED: Bos taurus 
hypothetical LOC618274 
(LOC618274) 
solute carrier family 16 
(monocarboxylic acid transporters), 
member 11 
SLC16A11 XR_028672 DV549159 618274 162515 1.9 1.0 4.0 16.9 8.5 1.32 0.00 0.00 2 
Homo sapiens SRY (sex 
determining region Y)-box 17 
(SOX17) 
SRY (sex determining region Y)-box 
17 
SOX17 NM_022454   64321 1.0 1.1 2.4 4.8 2.0 0.75 0.00 0.00 2 
Homo sapiens Sp3 transcription 
factor (SP3) 
Sp3 transcription factor SP3 NM_003111   6670 1.8 1.0 2.3 3.4 2.3 0.36 1.02 9.36 2 
Bos taurus transglutaminase 2 (C 
polypeptide, protein-glutamine-
gamma-glutamyltransferase) 
(TGM2) 
transglutaminase 2 (C polypeptide, 
protein-glutamine-gamma-
glutamyltransferase) 
TGM2 NM_177507 DV549153 281528 7052 2.0 1.0 2.9 10.6 5.8 0.69 0.00 0.02 2 
PREDICTED: Bos taurus tight 
junction protein 1 (zo1), partial 
mRNA 
tight junction protein 1 (zona 
occludens 1) 
TJP1 XM_582218  407102 7082 1.5 1.0 2.9 3.5 2.2 0.46 0.18 0.00 2 
55147 MARC 1BOV Bos taurus 
cDNA 5' 
transmembrane protein 146 TMEM146 AW417843 DV549291 617472 257062 1.0 1.5 2.4 2.1 2.7 0.45 0.18 0.25 2 
Homo sapiens TSC22 domain 
family, member 3 (TSC22D3), 
transcript variant 1 
TSC22 domain family, member 3 TSC22D3 NM_198057   1831 1.0 1.0 1.5 4.7 2.6 0.76 0.00 0.02 2 
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Bos taurus similar to Tetraspanin-7 
(Tspan-7) (Transmembrane 4 
superfamily member 2) (Cell surface 
glycoprotein A15) (T-cell acute 
lymphoblastic leukemia associated 
antigen 1) (TALLA-1) (Membrane 
component, X chromosome, surface 
marker 1) (CD231 antigen)... 
(MGC139832) 
tetraspanin 7 TSPAN7 NM_001076384  282383 7102 1.0 1.1 1.7 3.1 3.6 0.70 0.00 0.00 2 
PREDICTED: Bos taurus similar to 
TXNIP, transcript variant 1 
(LOC506790) 
thioredoxin interacting protein TXNIP XM_583286 EB086788 506790 10628 1.3 1.0 2.8 3.5 3.7 0.58 0.00 0.00 2 
Bos taurus similar to WAP four-
disulfide core domain protein 2 
precursor (Major epididymis-specific 
protein E4) (Epididymal secretory 
protein E4) (Putative protease 
inhibitor WAP5) (MGC127126) 
WAP four-disulfide core domain 2 WFDC2 NM_001076490  618044 10406 1.0 1.2 3.2 2.2 1.4 0.46 0.10 0.00 2 
Bos taurus XIAP associated factor-1 
(BIRC4BP) 
XIAP associated factor-1 XAF1 NM_001035075 DV936301 509740 54739 1.1 1.0 1.6 1.9 1.5 0.36 1.02 8.98 2 
Homo sapiens cDNA FLJ34585 fis, 
clone KIDNE2008758; 
Contig146999, ChrUn.1825, 
ENSBTAG00000011928 
zinc finger and BTB domain 
containing 20 
ZBTB20 AK091904 EB086567  26137 1.0 1.2 1.9 1.9 1.9 0.40 0.43 3.49 2 
Bos taurus similar to Actin, aortic 
smooth muscle (Alpha-actin-2) 
(MGC127800) 
actin, alpha 2, smooth muscle, aorta ACTA2 NM_001034502 EB086528 281593 59 3.2 3.2 1.4 1.8 1.0 0.49 0.00 0.00 3 
Bos taurus actin, gamma 2, smooth 
muscle, enteric (ACTG2) 
actin, gamma 2, smooth muscle, 
enteric 
ACTG2 NM_001013592 DV549238 281595 72 2.2 1.8 1.0 1.3 1.6 0.37 0.77 7.16 3 
Bos taurus similar to Protein 
C10orf58 precursor (MGC128811) 
chromosome 10 open reading frame 
58 
C10orf58 NM_001034599  534049 84293 6.6 5.9 1.0 1.1 3.3 0.52 0.00 0.00 3 
Contig112791, ChrUn.3510, 
ENSBTAG00000009291 
chromosome 20 open reading frame 
26 [Homo sapiens] 
C20orf26    26074 3.3 3.4 1.0 1.4 1.0 0.63 0.00 0.00 3 
PREDICTED: Bos taurus similar to 
8D6 antigen, transcript variant 1 
(LOC505043) 
CD320 molecule CD320 XM_581266  505043 51293 2.6 2.1 1.0 1.2 1.1 0.57 0.00 0.00 3 
PREDICTED: Bos taurus collagen, 
type IV, alpha 1 (COL4A1) 
collagen, type IV, alpha COL4A1 XM_580317  282191 1282 2.6 2.2 1.3 1.2 1.0 0.44 0.36 2.49 3 
PREDICTED: Bos taurus similar to 
FLJ20273 protein, transcript variant 
1 (LOC540831) 
RNA-binding protein FLJ20273 XM_613340 DV549106 540831 54502 1.5 2.5 1.2 1.4 1.0 0.42 0.30 2.18 3 
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PREDICTED: Bos taurus similar to 
folate receptor 1 precursor, 
transcript variant 1 (LOC516067) 
folate receptor 1 (adult) FOLR1 XM_594203  516067 2348 3.9 8.4 1.0 6.7 2.4 0.36 1.02 9.27 3 
PREDICTED: Bos taurus similar to 
gastrin-releasing peptide isoform 2 
preproprotein (LOC615323) 
gastrin-releasing peptide GRP XM_867101 DV549218 280809 2922 4.7 3.8 1.0 2.0 1.7 0.53 0.00 0.00 3 
Homo sapiens insulin-like growth 
factor binding protein 2, 36kDa 
(cDNA clone MGC:10918 
IMAGE:3627826), complete cds 
insulin-like growth factor binding 
protein 2, 36kDa 
IGFBP2 BC004312 DV936267 282260 3485 4.8 2.3 1.0 1.4 2.0 0.45 0.18 0.25 3 
Bos taurus insulin-like growth factor-
binding protein 6 (IGFBP6) 
insulin-like growth factor binding 
protein 6 
IGFBP6 NM_001040495 DV549250 404186 3489 1.6 2.0 1.1 1.2 1.0 0.36 1.02 8.44 3 
Bos taurus immunoglobulin IgA 
heavy chain constant region gene, 
partial cds 
immunoglobulin heavy constant 
alpha 
IGHA AF109167  281242  1.8 1.8 1.0 1.4 1.8 0.46 0.10 0.00 3 
Bos taurus myosin, light peptide 6, 
alkali, smooth muscle and non-
muscle (MYL6) 
myosin, light peptide 6, alkali, 
smooth  muscle and non-muscle 
MYL6 NM_175780  281341 4637 1.9 1.6 1.0 1.5 1.4 0.36 1.48 9.75 3 
Bos taurus nascent-polypeptide-
associated complex alpha 
polypeptide (NACA) 
nascent-polypeptide-associated 
complex alpha polypeptide 
NACA NM_001014916 DV549303 513312 4666 1.7 1.8 1.0 1.4 1.2 0.42 0.30 1.94 3 
Bos taurus nucleoside 
phosphorylase (NP) 
nucleoside phosphorylase NP NM_001007818  493724 4860 2.7 2.1 1.0 2.6 2.4 0.41 0.43 2.88 3 
Bos taurus neuropeptide Y (NPY) neuropeptide Y NPY NM_001014845  504216 4852 8.9 26.3 1.2 1.0 1.0 0.98 0.00 0.02 3 
Bos taurus similar to procollagen C-
endopeptidase enhancer 
(MGC137826) 
procollagen C-endopeptidase 
enhancer 
PCOLCE NM_001045888 DV549261 504471 5118 2.0 3.0 1.0 1.0 1.2 0.47 0.10 0.05 3 
Bos taurus calbindin 3, (vitamin D-
dependent calcium binding protein) 
(CALB3) 
S100 calcium binding protein G S100G NM_174257 EB086449 281658 795 3.8 4.0 1.0 5.6 2.1 0.45 0.31 1.94 3 
PREDICTED: Bos taurus similar to 
SPIN protein, transcript variant 1 
(LOC541068) 
spindlin 1 SPIN1 XM_614403  541068 10927 1.7 1.6 1.0 1.2 1.8 0.36 1.02 8.56 3 
Homo sapiens signal sequence 
receptor, gamma (translocon-
associated protein gamma) (SSR3) 
signal sequence receptor, gamma 
(translocon-associated protein 
gamma) 
SSR3 NM_007107   6747 1.7 2.0 1.0 1.5 1.2 0.39 0.61 5.38 3 
Homo sapiens stanniocalcin 
precursor (STC) mRNA, complete 
cds 
stanniocalcin 1 STC1 NM_003155  338078 6781 3.3 3.4 1.0 1.3 1.8 0.48 0.05 0.00 3 
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Bos taurus tissue inhibitor of 
metalloproteinase 1 (erythroid 
potentiating activity, collagenase 
inhibitor) (TIMP1) 
tissue inhibitor of metalloproteinase 
1 (erythroid potentiating activity, 
collagenase inhibitor) 
TIMP1 NM_174471  282092 7076 3.4 3.1 1.0 2.2 1.7 0.59 0.00 0.00 3 
Bos taurus uterine milk protein 
precursor (LOC286871) 
uterine milk protein precursor UTMP NM_174797 DV936167 286871  87.0 38.0 1.0 3.2 3.9 0.64 0.07 0.61 3 
Bos taurus vacuolar protein sorting 
protein 25 (VPS25) 
vacuolar protein sorting 25 (yeast) VPS25 NM_001015657 DV549245 534750 84313 1.5 2.0 1.1 1.1 1.0 0.36 1.48 9.84 3 
Bos taurus zinc finger and BTB 
domain containing 16 (ZBTB16) 
zinc finger and BTB domain 
containing 16 
ZBTB16 NM_001037476  534401 7704 2.3 2.5 1.0 1.1 1.6 0.43 0.24 0.98 3 
Homo sapiens chromosome 10 
clone RP11-472G21, complete 
sequence 
zinc finger protein 564 ZNF564 AC073370 DV549278  163050 1.8 2.1 1.0 1.1 1.0 0.37 0.77 7.09 3 
Bos taurus differentiated embryo 
chondrocyte expressed gene 1 
(BHLHB2) 
basic helix-loop-helix domain 
containing, class B, 2 
BHLHB2 NM_001024929  506945 8553 6.5 4.5 1.8 1.0 3.4 0.54 0.00 0.00 4 
BovGen_23410 normal cattle brain 
Bos taurus cDNA clone 
RZPDp1056B2138Q 5' sequence; 
Contig138689, Chr.11 
carnitine acetyltransferase CRAT CO895085  512902 1384 2.6 4.1 1.5 1.0 1.6 0.61 0.00 0.00 4 
Bos taurus cathepsin K 
preproprotein (CTSK) 
cathepsin K (pycnodysostosis) CTSK NM_001034435 DV549304 513038 1513 2.2 3.2 1.5 1.0 1.9 0.51 0.00 0.00 4 
PREDICTED: Bos taurus similar to 
dynein, axonemal, heavy 
polypeptide 9 isoform 2 
(LOC617408) 
dynein, axonemal, heavy 
polypeptide 9 
DNAH9 XM_597805  497209 1770 2.0 3.1 1.5 1.0 1.5 0.56 0.00 0.00 4 
Bos taurus similar to guanylate-
binding protein 5 (MGC142842) 
guanylate binding protein 5 GBP5 NM_001075746 DV936326 516949 115362 1.9 2.1 1.6 1.0 2.0 0.37 1.02 8.06 4 
Bos taurus heat shock 90kD protein 
1, alpha (HSPCA) 
heat shock protein 90kDa alpha 
(cytosolic), class A member 1 
HSP90AA1 NM_001012670 DV549307 281832 3320 2.2 1.8 1.5 1.0 2.2 0.39 0.61 4.98 4 
Bos taurus tumor rejection antigen 
(gp96) 1 (TRA1) 
heat shock protein 90kDa beta 
(Grp94), member 1 
HSP90B1 NM_174700  282646 7184 2.7 3.2 1.7 1.0 2.3 0.40 0.43 3.43 4 
PREDICTED: Bos taurus similar to 
tubulin, alpha 1, transcript variant 1 
(LOC539882) 
alpha tubulinalpha tubulin K-ALPHA-1 XM_590059  539882 10376 3.6 3.7 1.9 1.0 2.3 0.58 0.00 0.00 4 
PREDICTED: Bos taurus similar to 
mucin 16 (LOC528826) 
mucin 16 MUC16 XM_607258  528826 94025 1.9 2.3 1.3 1.0 1.0 0.38 0.77 6.47 4 
Chr.17 37693794-37693883, 
ENSBTAG00000014628 
2'-5' oligoadenylate synthetase 2 OAS2  DV936330 529660 4939 1.8 1.9 1.5 1.0 1.9 0.38 0.77 5.77 4 
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Bos taurus procollagen-proline, 2-
oxoglutarate 4-dioxygenase (P4HB) 
procollagen-proline, 2-oxoglutarate 
4-dioxygenase (proline 4-
hydroxylase), beta polypeptide 
(protein disulfide isomerase; thyroid 
hormone binding protein p55) 
P4HB NM_174135  281373 5034 2.0 2.7 1.5 1.0 1.2 0.50 0.05 0.00 4 
PREDICTED: Bos taurus similar to 
Proprotein convertase 
subtilisin/kexin type 5 precursor 
(Proprotein convertase PC5) 
(Subtilisin/kexin-like protease PC5) 
(PC6) (Subtilisin-like proprotein 
convertase 6) (SPC6) (LOC528098) 
proprotein convertase subtilisin/kexin 
type 5 
PCSK5 XM_868406 DV549237 616396 5125 3.9 8.8 1.4 1.0 1.2 1.01 0.00 0.01 4 
Bos taurus glucose regulated 
protein 58kD (GRP58) 
protein disulfide isomerase family A, 
member 3 
PDIA3 NM_174333  281803 2923 3.0 2.8 1.4 1.0 1.9 0.58 0.00 0.00 4 
Bos taurus protein disulfide 
isomerase-associated 4 (PDIA4) 
protein disulfide isomerase related 
protein 
PDIA4 NM_001045879  415110 9601 2.0 2.0 1.3 1.0 1.1 0.44 0.24 0.81 4 
Bos taurus profilin 1 (PFN1) profilin 1 PFN1 NM_001015592  513895 5216 2.2 2.5 1.3 1.0 1.6 0.43 0.24 0.98 4 
Bos taurus ribosomal protein L5 
(RPL5) 
ribosomal protein L5 RPL5 NM_001035306  515238 6125 1.8 2.7 2.1 1.0 2.0 0.36 1.02 9.66 4 
BP230006B10E12 Soares 
normalized bovine placenta Bos 
taurus cDNA clone 
BP230006B10E12 5' sequence 
ribosomal RNA processing 1 
homolog B (S. cerevisiae) [Homo 
sapiens] 
RRP1B AW461785  510240 23076 1.7 1.5 1.0 1.1 2.0 0.39 0.61 5.31 4 
Bos taurus similar to Collagen-
binding protein 2 precursor (Colligin 
2) (Rheumatoid arthritis related 
antigen RA-A47) (Serpin H2) 
(MGC127397) 
serine (or cysteine) proteinase 
inhibitor, clade H (heat shock protein 
47), member 1, (collagen binding 
protein 1) 
SERPINH1 NM_001046063  510850 871 2.8 3.0 1.5 1.0 1.1 0.49 0.33 2.66 4 
Bovine preprotachykinin B gene, 
exon 7 
tachykinin 3, neurokinin beta TAC3 M14352 EB086480 281513 6866 3.6 3.2 1.4 1.0 1.4 0.68 0.00 0.00 4 
Bos taurus similar to 30 kDa protein 
(MGC128026) 
transmembrane protein 111 TMEM111 NM_001035056  508371 55831 2.8 3.1 1.4 1.0 1.3 0.58 0.00 0.00 4 
Tumor Necrosis Factor Receptor 1 tumor necrosis factor receptor 
superfamily, member 1A 
TNFRSF1A NM_174674  282527 7132 7.4 6.9 2.8 1.0 2.0 0.78 0.00 0.01 4 
PREDICTED: Bos taurus similar to 
Tropomyosin 3, transcript variant 1 
(LOC512435) 
tropomyosin 3 TPM3 XM_589950  497019 7170 2.0 2.3 1.2 1.0 1.0 0.50 0.00 0.00 4 
Bos taurus hypothetical protein 
MGC139023 (MGC139023) 
zinc finger protein 22 (KOX 15) ZNF22 NM_001077108 DV549292 768051 7570 2.3 2.1 1.4 1.0 3.0 0.38 0.77 6.49 4 
Bos taurus actin, beta (ACTB) actin, beta ACTB NM_173979  280979 60 1.9 2.0 1.4 1.3 1.0 0.38 0.74 6.04 5 
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PREDICTED: Bos taurus similar to 
Angiopoietin-related protein 2 
precursor (Angiopoietin-like 2), 
transcript variant 1 (LOC512019) 
angiopoietin-like 2 ANGPTL2 XM_589455  512019 23452 2.6 3.2 2.3 1.0 1.2 0.45 0.18 0.00 5 
Bos taurus annexin A2 (ANXA2) annexin A2 ANXA2 NM_174716  282689 302 2.6 3.2 1.9 1.0 1.4 0.49 0.12 0.32 5 
Bos taurus ADP-ribosylation factor 3 
(ARF3) 
ADP-ribosylation factor 3 ARF3 NM_001015571  510994 377 2.1 2.1 1.6 1.4 1.0 0.44 0.18 0.40 5 
AAFC03019924, Chr.25, 
ENSBTAG00000018050 
cerebellar degeneration-related 
protein 2, 62kDa 
CDR2 AC092338   1039 2.8 3.5 1.8 1.0 1.2 0.61 0.00 0.00 5 
Bos taurus claudin 10 isoform b 
(CLDN10) 
claudin 10 isoform b CLDN10 NM_001014857  506545 9071 14.1 14.8 7.2 1.3 1.0 1.03 0.00 0.02 5 
PREDICTED: Bos taurus collagen, 
type XII, alpha 1, transcript variant 1 
(COL12A1) 
collagen, type XII, alpha 1 COL12A1 XM_611630 DV549301 359712 1303 4.6 8.8 3.5 1.0 1.8 0.78 0.00 0.01 5 
PREDICTED: Bos taurus similar to 
alpha 1 type XV collagen precursor 
(LOC537532) 
collagen, type XV, alpha 1 COL15A1 XM_617701 EB086518 537532 1306 3.3 3.1 2.2 1.1 1.0 0.60 0.00 0.00 5 
Bos taurus collagen, type I, alpha 2 
(COL1A2) 
collagen, type I, alpha 2 COL1A2 NM_174520 DV936377 282188 1278 2.3 4.0 2.5 1.4 1.0 0.68 0.00 0.01 5 
Bos taurus similar to Collagen alpha 
1(Tanaka, Jaradat et al.) chain 
precursor (LOC510833) 
collagen, type III, alpha 1 chain, fibril 
forming 
COL3A1 NM_001076831 EB086432 282190 1281 2.6 4.0 2.3 1.5 1.0 0.38 0.77 5.89 5 
PREDICTED: Bos taurus similar to 
alpha 3 type VI collagen isoform 3 
precursor, transcript variant 1 
(LOC530657) 
collagen, type VI, alpha 3 COL6A3 XM_609132  530657 1293 3.9 3.9 1.8 1.3 1.0 0.55 0.08 0.42 5 
Chr. 13, Contig26355, 
ENSBTAG00000012407 
forkhead box A2 FOXA2    3170 5.5 5.8 2.7 1.0 1.7 0.82 0.00 0.05 5 
Bos taurus insulin-like growth factor-
binding protein 4 (IGFBP4) 
insulin-like growth factor binding 
protein 4 
IGFBP4 NM_174557 DV549236 282262 3487 2.7 2.7 2.2 1.4 1.0 0.39 0.61 4.93 5 
Bos taurus lectin, galactoside-
binding, soluble, 1 (galectin 1) 
(LGALS1) 
lectin, galactoside-binding, soluble, 1 
(galectin 1) 
LGALS1 NM_175782 DV549275 326598 3956 2.6 4.0 2.1 1.1 1.0 0.72 0.00 0.00 5 
PREDICTED: Bos taurus similar to 
Equ c1, transcript variant 1 
(LOC513329) 
similar to Equ c1 LOC513329 XM_590993 DV549223 513329  2.8 5.7 2.5 1.2 1.0 0.82 0.00 0.06 5 
PREDICTED: Bos taurus similar to 
Leucine-rich repeats and calponin 
homology domain-containing protein 
3 (LOC506150) 
leucine-rich repeats and calponin 
homology (CH) domain containing 3 
LRCH3 XM_582557  506150 84859 4.1 4.0 2.2 1.4 1.0 0.55 0.00 0.00 5 
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Bos taurus similar to melanoma 
antigen family D, 1 (MGC128691) 
melanoma antigen, family D, 1 MAGED1 NM_001046125 DV549232 512562 9500 2.0 2.6 1.4 1.1 1.0 0.56 0.00 0.00 5 
Homo sapiens cDNA FLJ37829 fis, 
clone BRSSN2006611, weakly 
similar to Homo sapiens mRNA for 
mucolipidin 
mucolipin 3 MCOLN3 AK095148 DV549203 514345 55283 2.7 2.9 2.2 1.0 1.0 0.52 0.00 0.00 5 
Bos taurus microfibril-associated 
glycoprotein-2 (MAGP2) 
microfibrillar associated protein 5 MFAP5 NM_174386 DV549213 281908 8076 2.7 3.2 2.4 1.3 1.0 0.50 0.00 0.00 5 
PREDICTED: Bos taurus myosin, 
light polypeptide kinase (MYLK), 
partial mRNA 
myosin, light polypeptide kinase MYLK XM_590786 EB086410 338037 4638 1.8 3.2 1.8 1.3 1.0 0.47 0.22 1.73 5 
Homo sapiens nuclear receptor co-
repressor 2 (NCOR2) 
nuclear receptor co-repressor 2 NCOR2 NM_006312 DV549228  9612 2.8 3.0 2.0 1.0 1.1 0.50 0.00 0.00 5 
Bos taurus Norrie disease 
(pseudoglioma) (NDP) 
Norrie disease (pseudoglioma) NDP NM_001046090 DV549286 511596 4693 3.0 7.3 2.6 1.2 1.0 0.84 0.00 0.05 5 
PREDICTED: Bos taurus 
nephroblastoma overexpressed 
(NOV) 
nephroblastoma overexpressed 
gene 
NOV XM_582063  280879 4856 7.7 14.5 4.1 1.0 2.1 0.86 0.00 0.05 5 
LB01623.CR_H23 GC_BGC-16 Bos 
taurus cDNA clone IMAGE:8086441 
5' sequence; Chr.22 14335158-
14335617 
oxytocin receptor OXTR DT814146  281371 5021 21.0 17.6 13.9 1.0 4.8 0.93 0.00 0.02 5 
PREDICTED: Bos taurus similar to 
Pyruvate kinase, isozymes M1/M2 
(Pyruvate kinase muscle isozyme) 
(Cytosolic thyroid hormone-binding 
protein) (CTHBP) (THBP1) 
(LOC512571) 
pyruvate kinase, muscle PKM2 XM_590109 DV549269 512571 5315 2.0 2.5 1.4 1.1 1.0 0.44 0.24 0.78 5 
PREDICTED: Bos taurus similar to 
serum-inducible kinase, transcript 
variant 1 (LOC539449) 
polo-like kinase 2 (Drosophila) PLK2 XM_587229  539449 10769 4.9 5.1 3.2 1.0 1.4 0.63 0.00 0.00 5 
Bos taurus similar to retinoic acid 
receptor responder (tazarotene 
induced) 1 (MGC142566) 
retinoic acid receptor responder 
(tazarotene induced) 1 
RARRES1 NM_001075430  510102 5918 3.5 5.8 3.0 1.0 1.4 0.81 0.03 0.02 5 
Homo sapiens SAR1 protein (SAR1) SAR1 gene homolog A (S. 
cerevisiae) 
SAR1A NM_020150  517171 56681 4.3 6.4 2.8 1.0 1.9 0.72 0.00 0.00 5 
Bos taurus syndecan 2 (SDC2) syndecan 2 (heparan sulfate 
proteoglycan 1, cell surface-
associated, fibroglycan) 
SDC2 NM_001034788 EB086339 615785 6383 2.8 4.3 1.9 1.0 1.3 0.78 0.00 0,01 5 
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Bos taurus similar to Translocon-
associated protein, delta subunit 
precursor (TRAP-delta) (Signal 
sequence receptor delta subunit) 
(SSR-delta) (MGC133642) 
signal sequence receptor, delta 
(translocon-associated protein delta) 
SSR4 NM_001038503  504438 6748 2.1 2.1 1.6 1.4 1.0 0.40 0.61 4.28 5 
Angiopoietin receptor tie2 TEK tyrosine kinase, endothelial 
(venous malformations, multiple 
cutaneous and mucosal) 
TEK X71424  280939 7010 9.5 9.0 3.6 1.0 2.3 0.73 0.00 0.00 5 
PREDICTED: Bos taurus 
transmembrane prostate androgen-
induced protein (TMEPAI) 
transmembrane, prostate androgen 
induced RNA 
TMEPAI XM_001249927  617469 56937 3.5 4.3 2.9 1.1 1.0 0.84 0.00 0.02 5 
Bos taurus thymosin, beta 10 
(TMSB10) 
thymosin, beta 10 TMSB10 NM_174623  282385 9168 1.8 2.5 1.7 1.2 1.0 0.46 0.10 0.00 5 
Bos taurus similar to Tenascin 
precursor (TN) (Hexabrachion) 
(Cytotactin) (Neuronectin) (GMEM) 
(JI) (Miotendinous antigen) (Glioma-
associated-extracellular matrix 
antigen) (GP 150-225) (Tenascin-C) 
(TN-C) (MGC140517) 
tenascin C (hexabrachion) TNC NM_001078026  540664 3371 11.0 12.5 5.2 1.0 1.7 0.89 0.00 0.01 5 
Bos taurus similar to thyroid 
hormone receptor interactor 6 
(MGC128885) 
thyroid hormone receptor interactor 
6 
TRIP6 NM_001035469  615869 7205 1.9 3.1 1.7 1.2 1.0 0.57 0.00 0.00 5 
PREDICTED: Bos taurus similar to 
tubulin, alpha 1, transcript variant 1 
(LOC539882) 
tubulin, alpha 1 TUBA1 XM_590059 EB086372 504244 7277 3.0 2.9 2.1 1.0 1.6 0.55 0.00 0.00 5 
Bos taurus similar to tubulin, beta 5 
(MGC128415) 
tubulin, beta polypeptide TUBB NM_001046549 DV549268 281555 203068 2.6 2.6 1.8 1.0 1.1 0.55 0.08 0.24 5 
Bos taurus apolipoprotein E (APOE) apolipoprotein E APOE NM_173991 DV549312 281004 348 2.9 2.7 2.7 1.0 1.1 0.45 0.27 1.75 6 
PREDICTED: Bos taurus similar to 
SMAP-2b (LOC615490), partial 
mRNA 
bromodomain containing 8 BRD8 XM_867313  615490 10902 2.7 1.5 1.8 1.3 1.0 0.41 0.30 2.53 6 
Homo sapiens hypothetical protein 
FLJ14054 (FLJ14054) 
chromosome 5 open reading frame 
23 
C5orf23 NM_024563 EB086552  79614 3.5 3.8 3.9 1.0 1.3 0.75 0.00 0.00 6 
Homo sapiens collagen, type I, 
alpha 1 (COL1A1) 
collagen, type I, alpha 1 COL1A1 NM_001034039 EB086390 282187 1277 2.6 4.7 3.0 1.8 1.0 0.72 0.00 0.01 6 
PREDICTED: Bos taurus similar to 
Collagen, type VI, alpha 1, transcript 
variant 1 (LOC511422) 
collagen, type VI, alpha 1 COL6A1 XM_588755 EB086516 282193 1291 2.1 2.0 1.9 1.3 1.0 0.39 0.61 5.33 6 
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Homo sapiens deiodinase, 
iodothyronine, type II (DIO2), 
transcript variant 1 
deiodinase, iodothyronine, type II DIO2 NM_013989 EB086556 494548 1734 3.1 4.3 4.5 1.0 1.0 0.72 0.00 0.00 6 
Chr.21 22010999-22011118, locus 
for similar to fumarylacetoacetate 
hydrolase (fumarylacetoacetase) 
[Homo sapiens] 
fumarylacetoacetate hydrolase 
(fumarylacetoacetase) 
FAH NM_000137  508724 2184 2.1 3.7 3.0 1.0 1.0 0.56 0.00 0.00 6 
PREDICTED: Bos taurus similar to 
fibulin 1 isoform C precursor, 
transcript variant 2 (LOC514588) 
fibulin 1 FBLN1 XM_882469 DV549206 514588 2192 2.4 2.4 2.9 1.0 1.1 0.52 0.00 0.00 6 
PREDICTED: Bos taurus similar to 
fibroblast growth factor receptor-like 
1 precursor (LOC532327) 
fibroblast growth factor receptor-like 
1 
FGFRL1 XM_610839  532327 53834 1.9 2.6 2.5 1.5 1.0 0.46 0.18 0.00 6 
PREDICTED: Bos taurus protease, 
serine, 11 (PRSS11) 
HtrA serine peptidase 1 HTRA1 XM_612097 DV549249 282326 5654 2.4 3.2 3.3 1.5 1.0 0.48 0.34 2.74 6 
PREDICTED: Bos taurus 
hypothetical LOC539467 
(LOC539467), partial mRNA 
hypothetical LOC539467 LOC539467 XM_587378  539467 91461 4.5 3.5 3.8 1.0 1.1 0.69 0.00 0.00 6 
Bos taurus peroxiredoxin 2 (PRDX2) peroxiredoxin 2 PRDX2 NM_174763 DV549240 286793 7001 3.4 3.5 2.9 1.8 1.0 0.54 0.00 0.00 6 
PREDICTED: Bos taurus similar to 
Protein patched homolog 2 (PTC2) 
(LOC507948) 
patched homolog 2 (Drosophila) PTCH2 XM_584648 DV549226 507948 8643 2.1 3.5 3.5 1.6 1.0 0.47 0.10 0.00 6 
Bos taurus secreted protein, acidic, 
cysteine-rich [osteonectin] (SPARC) 
secreted protein, acidic, cysteine-
rich [osteonectin] 
SPARC NM_174464  282077 6678 2.9 4.1 2.9 1.6 1.0 0.60 0.18 1.18 6 
1404210 MARC 7BOV Bos taurus 
cDNA 3' sequence; Contig11724, 
Chr.21 
unknown unknown DN740440    2.2 3.1 2.5 1.0 1.0 0.58 0.00 0.00 6 
Bos taurus brain ribonuclease 
(BRB); most similar hsa protein: 
ribonuclease, RNase A family, 1 
(pancreatic) 
brain ribonuclease BRB NM_173891 EB086532 280720 6035 1.3 1.2 2.2 1.0 1.0 0.37 1.02 7.88 7 
PREDICTED: Bos taurus desmin, 
transcript variant 1 (DES) 
desmin DES XM_588095  280765 1674 2.4 1.9 3.4 1.6 1.0 0.44 0.24 0.53 7 
PREDICTED: Bos Taurus 
hypothetical LOC539299, transcript 
variant 1 (LOC539299) 
DNA polymerase-transactivated 
protein 6 
DNAPTP6 XM_586302 EB086800 539299 26010 1.0 1.1 2.4 1.1 1.0 0.53 0.00 0.00 7 
PREDICTED: Bos taurus similar to 
dystonin isoform 1eA, transcript 
variant 1 (LOC535297) 
dystonin DST XM_001252266 EB086418 535297 667 1.6 1.4 2.1 1.0 1.0 0.38 0.77 6.62 7 
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Bos taurus estrogen receptor 1 
alpha (ESR1) mRNA, partial 
sequence 
estrogen receptor 1 ESR1 AY656813 EB086353 281145 2099 1.9 1.7 3.1 1.0 1.2 0.45 0.18 0.00 7 
PREDICTED: Bos taurus similar to 
tumor endothelial marker 5 
(LOC782287); Contig84952, Chr.27, 
ENSBTAG00000008814 
G protein-coupled receptor 124 
(tumor endothelial marker 5) 
GPR124 XM_001250919  782287 25960 1.3 1.9 2.6 1.3 1.0 0.56 0.00 0.00 7 
BP107321 ORCS bovine utero-
placenta cDNA Bos taurus cDNA 
clone  ORCS10659 3' sequence 
immunoglobulin superfamily, 
member 1 
IGSF1 BP107321   3547 1.2 1.7 2.0 1.7 1.0 0.42 0.30 1.93 7 
PREDICTED: Bos taurus similar to 
laminin alpha 4 (LOC529670) 
laminin, alpha 4 LAMA4 XM_608123  529670 3910 1.0 1.5 3.2 1.4 1.3 0.49 0.00 0.00 7 
PREDICTED: Bos Taurus 
hypothetical LOC616148 
(LOC616148); Contig59859, 
ChrUn.3223, 
ENSBTAG00000026111 
hypothetical LOC616148 [Bos 
taurus]; limb bud and heart 
development homolog (mouse) 
LBH XM_868111  616148 81606 2.1 1.8 3.2 1.0 1.1 0.41 0.43 3.21 7 
Bos taurus isolate 32027 
mitochondrion, complete genome 
mitochondrially encoded cytochrome 
b 
MT-CYB AY676873  3283889 4519 1.8 3.2 2.9 1.0 1.8 0.41 0.48 3.64 7 
Homo sapiens ornithine 
decarboxylase antizyme 1 (OAZ1) 
ornithine decarboxylase antizyme 1 OAZ1 NM_004152  531865 4946 1.0 1.2 2.0 1.0 1.1 0.44 0.18 0.35 7 
Bos taurus vimentin (VIM) vimentin VIM NM_173969 DV936193 280955 7431 2.0 2.3 3.0 1.4 1.0 0.55 0.06 0.11 7 
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